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Abstract  
Candida yeast species are widespread opportunistic microbes, which are usually 
innocent opportunists unless the systemic or local defense system of the host becomes 
compromised. When they adhere on a fertile substrate such as moist and warm, protein-
rich human mucosal membrane or biomaterial surface, they become activated and start 
to grow pseudo and real hyphae. Their growth is intricately guided by their ability to 
detect surface defects (providing secure “hiding”, thigmotropism) and nutrients (source 
of energy, chemotropism).  
The hypothesis of this work was that body mobilizes both non-specific and specific 
host defense against invading candidal cells and that these interactions involve resident 
epithelial cells, rapidly responding non-specific protector neutrophils and mast cells as 
well as the antigen presenting and responding dendritic cell – lymphocyte – plasma cell 
system. It is supposed that Candida albicans, as a result of darwinistic pressure, has 
developed or is utilizing strategies to evade these host defense reactions by e.g. 
adhering to biomaterial surfaces and biofilms. 
The aim of the study was to assess the host defense by taking such key molecules of the 
anti-candidal defense into focus, which are also more or less characteristic for the main 
cellular players in candida-host cell interactions. 
As a model for candidal-host interaction, sections of chronic hyperplastic candidosis 
were used and compared with sections of non-infected leukoplakia and healthy tissue.  
In this thesis work, neutrophil-derived anti-candidal α-defensin was found in the 
epithelium, not only diffusely all over, but as α-defensin-rich front. Once they reach the 
epithelium, neutrophils, which form the major immigrant host defense cell, organize 
themselves into microabscess structures (study I). Mast cells, in addition to tumour 
necrosis factor-α, were found to contain preformed receptor activator of nuclear factor 
kappa B ligand (study II). This is important for the recruitment and maturation of 
antigen presenting dendritic cells and T lymphocyte activation (study III).The presence 
and effects of the chemokine interleukin-8 on the chemotaxis and transmigration of 
neutrophils was studied (study IV). For the immune system to operate, it has to be 
invoked first by a set of innate receptors known as Toll-like receptors (TLRs). Only 
three classes of TLRs seem to be engaged in recognizing C. albicans, i.e. TLR2, TLR4 
and TLR6. Hypha-rich candidal infection appears to try to elude the host response 
through stimulating TLR2 rather than TLR4 (study V).  
 11
Chronic hyperplastic candidosis provides a system that is very useful to study local and 
systemic host factors, which under normal circumstances restrain C. albicans to a 
harmless commensal state, but failure of which may lead to chronic infection. 
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Anatomical & histological review of the oral cavity: 
The oral cavity can be divided into two parts: the vestibulum oris (vestibule) and the 
cavum oris proprium (oral cavity proper). The vestibular part is bordered by the lips 
and cheeks on the outer side and by the teeth and alveolar ridges on its inner side. The 
oral cavity proper part lies within the dental arches and bones of the jaw, being limited 
posteriorly toward the pharynx by the anterior pillars of the fauces which is the passage 
between the back of the mouth and the pharynx (Fig.1, A&B). The oral cavity is mostly 
lined with mucous membrane and its underlying musculature and connective tissue. 
The morphologic structure of the oral mucous membrane varies according to the 
functional requirements in different areas of the oral cavity and the mechanical 
influences which affect them. In case of considerable mechanical influences, e.g. 
around the teeth, on the surface of tongue and on the hard palate where the epithelium 
comes in contact with the rough surface of masticated food, the  
mucosa is keratinized 
and attached densely to 
the underlying tissue and 
/ or bone. In other areas 
of the mouth where 
chewing is not primary 
concern, the mucosa is 
nonkeratinized, loose and 
unsupported by bone e.g. 
labial and buccal regions. The same applies in those areas which are well-protected 
with other tissues e.g. the floor of the mouth which is covered with the tongue. Due to 
its unique function in chewing and tasting, the dorsum of the tongue is covered with a 
mosaic of keratinized and nonkeratinized epithelium and specialized foliate, fungiform 
and circumvallate  papillae which contain the taste buds (Squier and Kremer 2001).  
The oral mucous membrane is composed of two layers, 1) surface epithelium which 
covers 2) underlying connective tissue. The lamina propria is the name used for the 
connective tissue component of oral mucosa.  
Figure 1 showing a schematic illustration A, and extraoral 
photograph B, of the oral cavity (modified from a website) 
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Epithelium 
The oral mucosa, which is covered by stratified squamous epithelium, is traditionally 
classified into three main types, keratinized, nonkeratinized and specialized. The 
epithelial covering of the oral mucosa consists of several layers of cells which flatten as 
they reach the surface. The deepest or the innermost layer which rests on the basement 
membrane is called basal layer (stratum basale) and consists of cuboidal cells. Next to 
the basal layer is a number of layers of polyhedral cells which form the prickle cell 
layer (stratum spinosum), the name of which was derived from the prickly appearance 
of the connected cells by their intercellular bridges. The cells of the prickle-cell layer 
flatten out when they pass into the next two layers; the granular and keratinous. The 
granular layer (stratum granulosum) is called so because its cells contain keratohyaline 
granules. The surface of oral epithelium is covered with the last keratinous layer which 
contains dead cells filled with keratin (only in the keratinized areas of the oral cavity). 
The keratinized layer may take up two morphological forms, orthokeratinized or 
parakeratinized, with the main difference between the two being the retainment of 
pyknotic nuclei in the cells of the latter.   
The epithelium of the oral cavity does not contain blood vessels although some of the 
nerves actually pass into it. Papillae of underlying connective tissue protrude toward the 
epithelium.  
The epithelium forms reciprocal ridges that protrude toward the lamina propria. These 
ridges interdigitate with the papillae and are called epithelial ridges or rete pegs. The 
epithelium is separated from its underlying lamina propria by means of a basement 
membrane.  
Lamina propria 
The lamina propria of the oral mucosa is a dense connective tissue layer of variable 
thickness. It lies below and supports the overlying stratified epithelium. Its papillae 
contain both blood vessels and nerves important also for the epithelium. The papillae 
are arranged in such a way that the surface area of contact between the lamina propria 
and epithelium is increased to facilitate exchange of material e.g. nutrients. The lamina 
propria can be divided into two parts; the papillary superficial part located just beneath 
the epithelium containing papillae, and the reticular deeper part. Besides blood vessels 
and nerves, the lamina propria consists of other components of the dense and loose 
connective tissue e.g. lymphatics, ducts of glands, and sense organs.  
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The lamina propria is further attached to an underlying connective tissue called 
submucosa. 
Submucosa 
Submucosa is the connective tissue which lies below the lamina propria and which 
attaches the oral mucous membrane to the underlying bony or muscular tissues. This 
tissue contains blood vessels which divide into smaller branches, nerves and adipose 
tissue. The blood vessel system in this tissue divides into subepithelial capillary 
network in the papillae, and is accompanied by venous and lymphatic vessels. The 
sensory nerves, which traverse the submucosa, are myelinated but just before they form 
their terminal parts lose their myelin sheath and turn unmyelinated. This portion of the 
oral cavity may contain minor salivary glands.  
Salivary glands & saliva  
The oral mucosa is bathed continually with a clear fluid, saliva, which is mostly 
secreted by three major paired glands, the parotid, the submandibular and the 
sublingual. In addition, there are numerous minor salivary glands, perhaps about 500 in 
number, scattered over most of the oral surfaces with the exception of the gingivae and 
the anterior third of the hard palate. All salivary glands, which are of merocrine type, 
empty their secretions into the oral cavity through excretory ducts (e.g. Stensen’s and 
Wharton’s ducts).  
Apart from water, the other major constituents of saliva are mucus, α-amylase, lipase, 
electrolytes and growth factors (Kagami, Hiramatsu et al. 2000). Besides, saliva, whose 
electrolyte composition is different from plasma, contains shed epithelial cells, food 
debris and oral microbiota (Edgar 1992). The basic secretory units of salivary glands 
are clusters of cells called acinus (plural: acini). The basic morphology of acini differs 
according to the type of secretion so that the serous acini tend to be circular in shape 
while those producing mucinous secretions have a rather tubular morphology. These 
cells secrete a fluid that contains water, electrolytes, mucus and enzymes, all of which 
flow out of the acinus into the salivary ducts. Ducts of the salivary glands root out from 
acini as intercalated ducts, which unite to form striated ducts which further coalesce to 
form the excretory duct of the gland.   
Within the ducts the composition of the secretion is altered. The intercalated ducts add 
bicarbonate to the glandular secretions and reabsorb chloride ion from the primary-
produced saliva. The basal parts of striated duct cells are rich in mitochondriae whose 
alignment together with the basal folds forming the cellular compartments inhabitating 
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the mitochondria give the ducts a striated appearance (hence its name). The 
mitochondria of the striated ducts allow pumping of ions across the membrane, thus 
regulating the ion concentration of saliva, e.g. much of the sodium is actively 
reabsorbed, and potassium is secreted. These relatively small collecting ducts within 
salivary glands lead further into a larger terminal (excretory) duct whose main function 
is to eventually empty the saliva into the oral cavity. Both serous and mucous acini and 
terminal parts of the secretory intercalated duct system are surrounded by spindle-
shaped smooth muscle cells called myoepithelial cells which, by their contraction, help 
move the saliva from acini to the duct system and thus participate in the secretory 
process.  
Each major salivary gland is characterized by its own type of acini, which corresponds 
to the type of saliva it produces: 
• Parotid glands produce a serous, watery secretion  
• Submandibular glands produce a mixed serous and mucous secretion; 
however serous cells significantly outnumber the mucous cells.  
• Sublingual glands are mixed as well but mucous cells predominate.  
Secretion of saliva is under control of the autonomic nervous system, which in part 
controls both the volume and type of saliva secreted. Stimulation of the sympathetic 
division leads to a rather viscous secretion rich in proteins, while parasympathetic 
stimulation produces more watery saliva.   
Functions of saliva 
The most important functions of saliva are summarized below: 
1. Lubrication and binding: the mucin component of saliva lubricates and 
protects the oral structures by acting as a barrier against irritants. Lubrication 
aids in speech, mastication and swallowing (Tabak 1990). Lubrication of dry 
food solubilizes it so that it can be tasted. A salivary protein, gustin, seems to be 
essential for taste bud growth and development (de Almeida Pdel, Gregio et al. 
2008). Salivary mucins are extremely effective in binding masticated food into a 
slippery bolus that slides easily through the esophagus without inflicting 
damage to mucosa.  
2. Oral hygiene: saliva enhances oral health by its almost constant flushing oral 
tissues, which floats away food debris and microorganisms thereby keeping the 
mouth relatively clean and hindering microbial colonization. Saliva contains 
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antibacterial substances e.g. lysozyme, peroxidase, and lactoferrin, which can 
lyse many bacteria or prevent overgrowth of oral microbiota (Rudney 1995). 
Saliva participates in the immune response through IgA which it contains and 
which is known to inhibit bacterial attachment to the oral mucosa by means of 
clumping the bacterial cells together (Dowd 1999).    
3. Initiation of food digestion: saliva starts digestion of food. Serous acinar cells 
secrete an alpha-amylase which digests dietary starch into maltose. However, 
this function remains minor compared to the pancreatic amylase which breaks 
down the yet undigested starch in the intestine.   
4. Buffering action: the salivary content of bicarbonate and urea is of great 
importance in neutralizing the acidic environment of dental plaques, which 
protects against dental decay.  
5. Antisolubility: in the initial stages of dental caries, the hard tissue substance of 
the tooth (enamel) is dissolved most probably due to the acid produced by 
acidogenic bacteria. Thus, the mineralized constituents of enamel, calcium and 
phosphate, are liberated. Instead of losing theses essential minerals for good, 
saliva, already containing considerable calcium and phosphate, when it gets 
saturated with them partly with the aid of certain salivary proteins, tends to 
precipitate them again in the enamel (remineralization).  
 
 17
Fungi: Definition, taxonomy and characteristics 
Fungi are eukaryotic, plant-like microorganisms which are ubiquitously spread in 
nature. There are about 80,000 species of fungi which range from the simplest 
unicellular yeasts to the more complicated multicellular mushrooms and mildews.  
There are many ways to classify fungi, but the most common criterion upon which 
fungi can be classified is according to their manner of reproduction and formation of 
spores. With respect to reproduction, fungi are classified into five major groups:  
• Ascomycetes- characterized by production of microscopic spores inside 
elongated cells or sacs, known as asci. 
• Basidiomycetes- the spores in this group are produced on the end of specialised 
cells called basidia.  
• Deuteromycetes-this class includes all fungi which reproduce only by asexual 
spores without any known sexual reproduction. 
• Oomycetes-the life cycle of these fungi include two phases: asexual (through 
zoospore), and sexual (oospore) 
• Zygomycetes-the hyphae of these fungi form coencytic mycelia. They 
reproduce both asexually (chlamydospores) and sexually (formation of zygote). 
Fungi grow well in dark and moist conditions; hence they thrive most often in soil and 
aquatic environments. One of the important characteristics of fungi is that they lack 
chlorophyll and therefore draw their nutrition from decaying organic matter of living or 
dead plants and animals which they use as sources of energy. For that reason, fungi are 
considered heterotrophic and said to be saprophytes. Due to their lack of chlorophyll, 
modern biologists tend to place fungi in their own kingdom rather than in the plant 
kingdom as used to be previously.  
Many fungi play an important role in the natural cycle as they decompose organic 
matters and return their end products to the soil. Fungi are even used for medical 
purposes, such as species within the penicillium genus which provide antibiotics, e.g. 
penicillin. 
There are two basic morphological varieties of fungi, yeasts and molds. Fungi in the 
yeast phase tend to form moist and shining colonies reproduce asexually and their cell 
walls are sometimes surrounded with a capsule, e.g. Cryptococcus neoformans. 
In contrast, fungi in the mold form consist of masses from which filamentous 
projections, known as hyphae, branch out. The hyphae may be septate (where the 
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multicellular hyphae are separated by crosswalls) or nonseptate (called coenocytes, 
multinucleate without partitions). Hyphae usually grow along a surface and branch 
together forming tufts, collectively called mycelium. Common septate filamentous 
fungi are Aspergillus, Fusarium, Cephalosporium, Paecilomyces, and Penicillium 
species. The nonseptate filamentous fungi include the Mucor species. 
Candida 
The genus Candida belongs to yeasts. It is also the most common cause of 
opportunistic mycoses worldwide. It is a frequent 
colonizer of human skin and mucous membranes. 
Candida is a member of normal flora of skin, mouth, 
vagina, and bowel. In addition to being a colonizer and a 
pathogen, it is found in the environment, particularly on 
leaves, flowers, water and soil. The genus Candida 
includes around 154 species. Among these, six are most 
frequently isolated in human infections. While Candida 
albicans is the most abundant and significant species, Candida tropicalis, Candida 
glabrata, Candida parapsilosis, Candida krusei, and Candida lusitaniae are also 
isolated as causative agents of Candida infections. Importantly, there has been a recent 
increase of infections due to non-albicans Candida spp., such as Candida glabrata and 
Candida krusei (Abi-Said, Anaissie et al. 1997). Patients receiving fluconazole 
prophylaxis are particularly at risk of developing infections due to fluconazole-resistant 
Candida krusei and Candida glabrata strains (Barchiesi, Morbiducci et al. 1993). The 
diversity of Candida spp. that are encountered in infections is expanding and the 
emergence of species that were rarely described in infections in the past is now likely 
(Blinkhorn, Adelstein et al. 1989). 
Candida albicans 
C. albicans belongs to the Ascomycota class of fungi and is the most commonly studied 
species because it causes a variety of mycotic infections in humans (Siqueira and Sen 
2004). 
Taxonomy 
? Kingdom: fungi 
? phylum: ascomycota  
? Subphylum: ascomycotina  
Figure 2 showing hyphae of C. albicans, CH.
(modified from a website) 
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? Class: ascomycetes  
? Order: saccharomycetales  
? Family: saccharomycetaceae  
? Genus: Candida  
? Species: albicans  
Morphology 
 The fungal pathogen C. albicans can be found in three morphological states as yeasts, 
hyphae or intermediate forms i.e. pseudohyphae (Sudbery, Gow et al. 2004) (Fig. 2, 3). 
Some mycologists prefer to consider the pseudohyphal and hyphal forms as one entity; 
therefore C. albicans is usually said to be dimorphic in nature as it has two distinct 
shapes. Yeast cells are unicellular and 
spherical or oval in shape, and normally 
form smooth, white dome-shaped 
colonies. Yeasts multiply by a specific 
process of mitotic division known as 
budding, in which daughter cells exude 
from the mother cells. Several classes of 
fungi, including C. albicans, are 
featured with the ability to form spores 
i.e. blastospores and chlamydospores 
(which are spherical, smooth surfaced 
and highly refractile (Nobile, Bruno et al. 
2003), thus more favorable for candidal survival). Pseudohyphae are considered 
modified yeasts which continued in polarized growth without separation from the 
mother cell at the end of each cell cycle (Sudbery, Gow et al. 2004). Pseudohyphae are 
also characterized by unequal width of their cellular projections, being wider at the 
center than at ends (Merson-Davies and Odds 1989). Hyphae are microscopic tubes 
which contain compartmentalized cell units separated by septa, these units arise 
initially from blastospores or also from already existing hyphae (Webb, Thomas et al. 
1998). When it takes up the hyphal form, it forms filamentous projections with parallel-
sided walls, so keeping the width of their compartments the same throughout the 
branched portion. Germ tube is a term applied to the projecting hyphae in the first cell 
cycle just before septation (Calderone, Suzuki et al. 2000).     
Figure 3 illustrating a drawing of the basic 
morphologies of C. albicans. a) yeast form, b) 
pseudohyphae, c) hyphae and d) Opaque 
CD
BA
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C. albicans is well known for its morphological plasticity, i.e. its ability to transform 
from one morphological pattern to another known as switching (Whiteway and 
Oberholzer 2004), which is thought to promote the pathogenicity of the organism (Lo, 
Kohler et al. 1997). There are other minor morphological changes which take place 
during switching. For example, opaque phase is a variety where the cell becomes 
oblong instead of the usual oval form of the yeast. Cell signal transduction pathways 
and various transcriptional effects have been linked to the different array of 
morphological forms and switching of C. albicans (Liu 2002; Dhillon, Sharma et al. 
2003).  
Biofilm formation 
Microorganisms can exist either in a floating planktonic state or attached to an external 
surface. A biofilm is an assembly of surface-coating microbial cells that is attached to 
the surface and enclosed in a matrix of polysaccharide material such as alginate, Psl and 
Pel-encoded polysaccahride (Donlan 2002; Ryder, Byrd et al. 2007).  
In addition to its association with many hospital acquired nosocomial infections (Potera 
1999) biofilm formation is of clinical significance since it confers the associated 
microorganisms an ability to resist external threats, e.g. antimicrobial drugs (Baillie and 
Douglas 2000; Mah and O'Toole 2001; Mukherjee, Chandra et al. 2003). A biofilm 
formed of C. albicans renders it a hundred times more resistant to the antifungal 
fluconazole and 20-30 times more resistant to amphotericin B than planktonic cells 
(Kumamoto 2002). Both yeast and hyphal forms of C. albicans can participate in 
biofilm formation. Due to biofilm formation, C. albicans yeast is considered as one of 
the most common microorganisms found in the bloodstream in hospitalized patients, in 
whom it originates from the biofilm composed of yeast cells embedded in a protective 
matrix of extracellular protein (Chaffin, Lopez-Ribot et al. 1998; Crump and Collignon 
2000; Soustre, Rodier et al. 2004). Biofilm of C. albicans has been noticed in dentures 
as well as other biomaterials, e.g. stents, shunts, endotracheal tubes and catheters 
(Andes, Nett et al. 2004; Bulad, Taylor et al. 2004). In order to form a biofilm C. 
albicans has to adhere first to a medical device, colonize it and then establish a biofilm. 
Biofilm formation by C. albicans depends on many factors, e.g. nature of the device 
surface, whether host-derived conditioning film is present and liquid flow (Chandra, 
Kuhn et al. 2001; Kuhn, Chandra et al. 2002). Colonization of different biomaterials by 
C. albicans has been accepted as an important major cause  of medical device failure 
(Jones, McGovern et al. 2001). In the biofilm composed of C. albicans a layer of yeast 
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cells is located lowermost attached to the device, follows a layer above the yeast layer 
composed of filamentous cells in the hyphal form surrounded by extensive exoplasmic 
matrix (Baillie and Douglas 1999). 
Biological behavior 
Generally speaking fungi have the ability to adapt themselves to different 
environmental conditions. Two important biological features seem to contribute to such 
adaptation, chemotropism and thigmotropism.  
Chemotropism is the growth of an organism along a concentration gradient toward a 
particular chemical in its environment. Despite some doubts, it is argued that C. 
albicans hyphal tips might excrete enzymes e.g. SAPs (secreted aspartyl proteinases), 
phospholipases, which break cellular components of the host, which are then sensed 
back by receptors located on the hyphal apices (Davies, Stacey et al. 1999). This might 
be used as a directional guidance for the candidal hyphae so they decrease or even stop 
growing in the surface plane and extend instead down to the underlying cellular tissue. 
Chemotropic response has been suggested to play a role when C. albicans infects the 
vascular endothelium from where the candidal hyphae grow down to the underlying 
cellular tissue due to chemical signals released 
from the endothelial cells and detected by the 
newly formed germ tubes (Rotrosen, Edwards et 
al. 1985).    
Thigmotropism is the ability of the organism to 
sense and respond to changes in surface 
topography upon which it rests. There are two 
types of thigmotropism. Positive thigmotropism 
causes an organism to grow toward an object and 
negative thigmotropism away from it. 
Thigmotropism has been demonstrated in hyphae of C. albicans (Sherwood, Gow et al. 
1992). This contact sensing phenomenon seems of importance in candidaemia where 
invasion of both epithelium and endothelium ensues. Although invasion of endothelium 
involves direct penetration of this layer without any requirement of surface exploration, 
epithelium is grown over by blastospore-derived hyphae prior to penetration (Filler, 
Swerdloff et al. 1995). This might indicate that thigmotropism can be of importance in 
both surface growth and invasion (Davies, Stacey et al. 1999). The molecular events 
involved in the regualtion of thigmotropism are not yet known.  
Figure 4 showing the creamy colored 
appearance of C. albicans in SDA. 
Permitted from Dr. David Ellis 
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Culture media  
In general, fungi are cultivated in three basic types of culture media, natural, 
dehydrated and synthetic.   
The most frequently used medium for culturing C. albicans is SDA (Sabouraud 
Dextrose Agar) which belongs to the dehydrated media. Basically it contains dextrose 
and beef extract and is useful in clinical applications since this culture medium allows 
growth of Candida while inhibiting growth of other microorganisms, e.g. bacteria. SDA 
is seldom used alone since it is estimated that more than one type of Candida species 
occurs in about 10% of oral samples (Williams and Lewis 2000). Examples of media 
used in combination with SDA include Pagano-Levin agar, or commercially available 
chromogenic agars (discussed in the next section). In SDA candidal colonies are white 
to cream colored with smooth contours and glabrous shape (Fig. 4).  
Identification 
There are many species of the genus Candida e.g. C. glabrata, C. krusei, and C. 
tropicalis. To differentiate C. albicans from the other species, certain identification 
tests must be employed. C. albicans can be distinguished from other species by means 
of three main criteria, chromogenic, morphological and physiological criteria. Only the 
chromogenic and morphological criteria will be clarified. 
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Table 1.  Chromogenic criteria in agar culture to differentiate C. albicans from 
other candida species.   
 Agar medium Basis of differentiation Candida sp. identified (color) 
Pagano-Levin Reduction of TTC  
(triphenyltetrazolium chloride) 
C. albicans (cream), 
other species (red or pink) 
CHROMagar 
Candida 
Chromogenic substrate for 
hexosaminidase  
C. albicans (green) 
C. tropicalis (blue), 
C. krusei (pale rose) 
Albicans ID Chromogenic substrate for 
hexosaminidase 
C. albicans (blue), 
other species (cream) 
 
 
Table 2. Morphological criteria to differentiate C. albicans from other Candida species 
(Williams and Lewis 2000). 
 
 
 
 
                    Morphology  
Candida species Germ tube Pseudohyphae Chlamydospores 
C. albicans + + + 
C. tropicalis some + some 
C. stellatoida + + some 
C. parapsilosis - + - 
C. krusei - + - 
C. guilliermondii - + - 
C. glabrata - - - 
C. kefyr - + - 
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Pathophysiology of Candida albicans infection 
   Relationship between C. albicans and the host 
• C. albicans as a component of the host microflora   
Candidal species are found in about 40-70% of healthy individuals, the main species 
found being C. albicans (Lo, Kohler et al. 1997; Watts, Very et al. 1998; Liu 2001; 
McCullough, Jaber et al. 2002). C. albicans comprises a component of the benign 
commensals living in a variety of body locations (Lo, Kohler et al. 1997; Lockhart, 
Pujol et al. 2002; Soll 2002). It belongs to the normal microbial flora which colonizes 
mucocutaneous surfaces asymptomatically e.g. oral cavity, gastrointestinal tract, 
genitourinary tract of healthy human host (Elahi, Pang et al. 2001; Newman, Bhugra et 
al. 2005). In the vagina C. albicans, which colonizes the epithelial surfaces of 5 – 25% 
of healthy women (Sobel 1988; Hauman, Thompson et al. 1993), is the causative agent 
of vulvovaginal candidosis which affects 50 – 75% according to estimates of those 
women at least once before their menopause (Kent 1991; Sobel 1992), while 5-10% 
have a recurrent type of vulvovaginal candidosis (Fidel 2005). 
 
• When does C. albicans cause infection? 
As mentioned above, candidal yeasts can form a part of the normal microflora of the 
body. Candidal infection ensues when the number of yeasts increases so it exceeds the 
tolerance of the host tissue and causes inflammation, e.g. mucositis. In other words, it is 
the immune host defense status of the host which is to be blamed rather than the 
microorganism itself since as long as the host defense is intact with proper functional 
integrity, the latter remains innocent. When the local or systemic host defense becomes 
compromised, the delicate balance between C. albicans and the host is broken and the 
fungus becomes pathogenic in which case it causes an infection called candidosis or 
candidiasis. Factors which alter the status of the local and / or general host defense and 
hence favor the growth of the candidal yeasts in the oral cavity will be discussed shortly 
below as predisposing factors. Therefore, candidal infections have received the 
designation “disease of the diseased”. Recently, the incidence of candidosis has 
increased which is mainly due to the increasing number of immunocompromised 
patients (McCullough, Jaber et al. 2002; Wellington, Bliss et al. 2003). Candidosis 
ranges from simple superficial oral and vaginal infections to life-threatening systemic 
candidosis in severely immunocompromised patients (Naglik, Newport et al. 1999; 
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Whiteway 2000). Biomaterials, when implanted to a host, form a good habitat for C. 
albicans to organize a biofilm community which in turn can contribute to disease 
(Kumamoto 2002).  
 
• Role of C. albicans in nosocomial infections & candidaemia 
C. albicans has been claimed to be the fourth most common nosocomial infectious 
agent (Schaberg, Culver et al. 1991; Ashman, Farah et al. 2004). In addition to the role 
of C. albicans in mucosal and mucocutaneous infections, it has an ability to invade also 
other vital systems in the body. In patients whose immunity is suppressed, these forms 
of invasive candidal infections, including blood-disseminated candidosis (candidal 
sepsis) are usually associated with high morbidity and mortality despite the use of 
appropriate antifungal agents (Fridkin and Jarvis 1996; Andriole 1999; Kao, Brandt et 
al. 1999). In susceptible hosts C. albicans enters the blood compartment and causes 
deep-seated infections in target organs (Ibrahim, Filler et al. 1998). Once in blood C. 
albicans may disclose its virulence factors and so the condition transits from 
candidaemia (mere presence of candida in the blood) to lethal septicemia (presence of 
symptoms caused by candidal toxins) the morbidity of which has been estimated to be 
around 50% (Edmond, Wallace et al. 1999; Barelle, Bohula et al. 2003).  
 
Oral candidosis 
• Definition and epidemiology 
Oral candidosis is an opportunistic infection of the oral cavity caused by the 
overgrowth of Candida species, usually of C. albicans (Fotos and Hellstein 1992; 
Muzyka and Glick 1995). Candida species are present as commensal organisms of the 
oral microbiota in about 20-60% of normal human population (MacFarlane TW 1989). 
In the mouth, the primary site where C. albicans is located is the dorsum of tongue, 
while other places such as tooth surfaces covered with plaque are less commonly 
colonized (Arendorf and Walker 1980). There are certain factors which affect the 
pattern of distribution of C. albicans in the mouth (Webb, Thomas et al. 1998). They 
may include: 
1. Saliva: One study showed that saliva has the ability to reduce candidal attachment to 
the acrylic surface of oral biomaterials (Samaranayake, McCourtie et al. 1980), 
although  mannoprotein on the surface of C. albicans may also selectively absorb 
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salivary mucins, which can enhance candidal attachment to acrylic (Edgerton, 
Scannapieco et al. 1993).  
2. pH: The exact pH at which C. albicans adheres best to oral cells cannot be defined 
precisely since the effect of pH varies considerably depending on the candidal strain 
and type of mucosal cell (Mehentee and Hay 1989) but generally speaking, low pH has 
been suggested to favor the growth and colonization of C. albicans.  
3. Adhesion: The interaction between oral cells and C. albicans is thought to be 
mediated through ligand-receptor interactions. Mannoprotein, for example, represents a 
ligand on the candidal surface while there are many mammalian cell proteins acting as 
receptors, e.g. iC3b, fibrinogen and laminin (Calderone and Braun 1991).    
4. Cell surface hydrophobicity: Candidal cells can be hydrophilic or hydrophobic 
depending on the composition of cell wall in the protein structure of the cell wall 
(Hazen, Lay et al. 1990).  When candidal cells are hydrophobic, they can bind diffusely 
to hydrophobic surfaces of host cells without ligand-receptor interactions to areas 
which are free of macrophages (Hazen, Brawner et al. 1991).    
5. Oral bacteria: The growth and colonization of C. albicans may be augmented by the 
presence of some bacteria e.g. Streptococcus sanguis, Streptococcus gordonii (Hsu, 
Minah et al. 1990).  
6. Hyphae: C. albicans is a biphasic fungus. The hyphal form is associated with more 
invasive potential than the yeast form (Kimura and Pearsall 1980). This is thought to be 
due to the release of some proteases during switching of C. albicans from the 
unicellular yeast to the hyphal form (Borg and Ruchel 1988; Cutler 1991). 
 
• Etiology and predisposing factors 
Among the 150 Candida species known today, the most common etiological 
microorganism of oral candidosis is C. albicans (Cannon, Holmes et al. 1995). This, 
however, does not preclude the other human pathogenic species from being direct 
causative agents in some cases of oral candidosis, namely C. parapsilosis, C. tropicalis, 
C. glabrata, C. krusei, C. pseudotropicalis, or even C. dubliniensis, which has first 
more recently been associated with oral candidosis in HIV-infected patients (Odds 
1988; Sullivan, Westerneng et al. 1995). There are many factors which predispose to 
the development of oral candidosis. These can act either by enhancing the growth and 
colonization of candidal yeast or suppressing the immune system of the host or both. 
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They are summarized in table 3. Some factors, which are considered common, are 
detailed further below. 
                     1) Prostheses  
Dental prosthesis, especially if they are ill-fitting and accompanied with poor oral 
hygiene, may become a substrate for candidal growth. Constant physical irritation can 
cause local microscopic breaches in the oral mucosa, which provide an entrance route 
to the fungus. It has been noticed that salivary yeast counts are much higher in patients 
wearing full dentures than in dentate subjects (Parvinen 1984). Since dental prostheses 
may restrict the diffusion of oxygen and flow of saliva to the underlying tissue, a local 
stagnant environment with a low pH and oxygen content may be produced. Such an 
environment favors fungal overgrowth and ingrowth into the porous acrylic resin 
matrix (Shay, Truhlar et al. 1997). C. albicans adheres avidly to denture-base materials 
in vitro and this has been attributed to its hydrophobicity (Radford, Challacombe et al. 
1999). 
                     2) Epithelial alterations 
Intact oral mucous membrane provides an effective physical barrier against ingress of 
fungal or bacterial cells. When the turnover rate of epithelial cells alters, e.g. due to 
radiation therapy or anticancer medication, the integrity of oral epithelial seal is 
impaired, which predisposes the mouth to candidal infection (Bunetel and Bonnaure-
Mallet 1996). 
                    3) Endocrine disorders 
Deficiencies of certain hormones predispose to the emergence of oral candidosis e.g. 
diabetes mellitus, hypothyroidism, hypoparathyroidism, hypoadenalism and Addison’s 
disease (Fotos and Hellstein 1992). More commonly, the mucocutaneous form of 
candidosis has been associated with multiple endocrine disorders (Firth, O'Grady et al. 
1997) where the triad of chronic mucocutaneous candidosis, hypoparathyroidism and 
adrenocortical failure comprise a compex condition known as APECED (Autoimmune 
Polyendocrinopathy-Candidosis-Ectodermal Dystrophy) (Perheentupa 2006). Studies 
have found that Candida species also in asymptomatic patients are more common in the 
oral cavity of diabetic patients than in healthy people (Dourov and Coremans-Pelseneer 
1987). Although it is still obscure, the mechanism of this overgrowth of Candida is 
thought to be xerostomia, elevated glucose levels and impaired neutrophil function 
(Rossie and Guggenheimer 1997).  
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                    4) Infectious and immunologic disorders 
The cell-mediated and humoral immunity are of paramount importance in protecting 
the oral mucosa against candidosis (Hedderwick and Kauffman 1997). Since Candida 
species are opportunistic pathogens, fungal infections are common in patients whose 
immune system is compromised, e.g. acquired immune deficiency syndrome (AIDS) in 
which more than 90% of affected patients at some stage of the disease develop oral 
candidosis (Ellepola and Samaranayake 2000). Human immune deficiency virus (HIV) 
alters cell-mediated immunity so that T-cell function becomes impaired. Oral 
candidosis in HIV +ve patients can take up a variety of expressions ranging from 
pseudomembranous, atrophic and hyperplastic, all of which resemble clinically the 
lesions seen in noninfected individuals. HIV-related oral candidosis can also extend 
beyond the frontiers of the oral cavity to involve other organs such as the esophagus 
and the trachea, which will cause dysphagia and restrosternal discomfort. Severe 
combined immunodeficiency syndrome (SCID) is another condition characterized by 
defects in the cell-mediated and humoral immune reactions. Chronic mucocutaneous 
candidosis is often noticed in patients with SCID. Patients on immunosuppressive 
drugs, e.g. following organ transplantation, are also susceptible to oral candidosis.  
 
Table 3. Summary of factors predisposing to oral candidosis  
Promote the growth of yeasts Suppress the host defense 
Intrinsic Extrinsic Local Systemic 
Imbalance of 
oral microflora 
High  carbohydrate 
diet 
Hyposalivation Extremity of age, i.e. 
infancy/senility 
Low pH Dental prostheses Epithelial changes Immunosuppressive 
infections e.g. AIDS 
Poor oral 
hygiene 
 Broad spectrum 
antibiotics 
Immunosuppressive 
therapy e.g. cortisone 
Already existing 
lesions e.g. 
leukoplakia 
 Malnutrition or 
malabsorption, e.g. 
iron deficiency 
Endocrinpathies e.g. 
diabetes 
  Radiation therapy Pregnancy 
  Heavy smoking  
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  Classification of oral candidosis 
Group 1: Candidosis confined to the oral mucosa 
1. Acute 
• Acute pseudomembranous candidosis (thrush) 
• Acute atrophic (erythematous) candidosis 
2. Chronic 
• Chronic atrophic candidosis (denture stomatitis) 
• Candida-associated angular cheilitis 
• Median rhomboid glossitis 
• Chronic hyperplastic candidosis (candidal leukoplakia) 
Group 2: Oral manifestations of generalized candidosis 
• Chronic mucocutaneous candidosis 
 
Clinical variants of oral candidosis: 
1) Acute pseudomembranous candidosis (thrush) 
This type is characterized by the presence of extensive white superficial patches. These 
curd-like patches are nothing but pseudomembranes consisting of desquamated 
epithelial cells, fibrin and fungal hyphae (Akpan and Morgan 2002). The 
pseudomembranes can be wiped off leaving an erythematous base. This lesion can be 
found anywhere in the oral cavity, most often on the dorsum of tongue or on labial and 
buccal mucosae. Young infants and old people are frequently affected.  
2) Acute atrophic candidosis 
This form of candidosis is also called acute erythematous candidosis. It is not as 
frequent as thrush except perhaps after the use of broad spectrum antibiotic, but when it 
occurs it causes painful burning sensation of the mouth (Lehner 1967). These lesions 
are characterized by red, atrophic changes occurring most commonly on the palate and 
tongue. Loss of tongue papillae (depapillation) leads to a bright red appearance and 
soreness (Palmer, Robinson et al. 1996). This clinical type of candidosis is commonly 
seen in HIV infections and after use of corticosteroids or broad-spectrum antibiotics. 
3) Chronic atrophic candidosis (denture stomatitis) 
This particular form is characterized by the presence of chronic erythematous and 
edematous lesions, which range from small to large. It affects at some stage about half 
of all complete denture wearers (Budtz-Jorgensen 1990). As the synonym suggests, it is 
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associated with ill-fitting and/or poorly cleaned dentures. Therefore, it tends to be 
found exclusively in the denture-wearing areas, especially the palate. Clinically, it 
manifests as bright red, somewhat velvety to pebbly surface. 
4) Candida-associated angular cheilitis 
Since angular cheilitis (perleche) is commonly associated with denture stomatitis, it 
belongs to the same category as chronic atrophic candidosis but has a different location 
(RA 1966; Budtz-Jorgensen 1974). As the name points, it affects the angles of the oral 
cavity (commissures) and it starts as fissures which allow pooling of saliva and 
incubation of candidal cells leading to erythematous lesions which may encrust or 
erode and hence turn painful. Other predisposing factors include deep nasolabial folds 
(Shay, Truhlar et al. 1997) and long-term use of dentures (Penhall 1980). 
5) Median rhomboid glossitis 
Median rhomboid glossitis is a chronic symmetrical depapillated area of the tongue 
anterior to the circumvallate papillae. The region of papillary atrophy is usually 
elliptical or rhomboid in shape and situated at the midline of the tongue (Scully, el-
Kabir et al. 1994). 
6) Chronic hyperplastic candidosis 
This clinical manifestation was the pivot of my study and is considered separately 
below in more detail. 
7) Chronic mucocutaneous candidosis  
This term, which comprises an array of clinical manifestations, is applied when the 
candidal infection involves organs other than the mouth e.g. skin, nail beds, vagina etc. 
Four subtypes have been recognized, associated with familial susceptibility; 
endocrinopathy; both familial susceptibility and endocrinopathy; and onset later than 10 
years of age (Higgs and Wells 1974). 
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Chronic hyperplastic candidosis (CHC)  
Lehner first reported the presence of candidal infection in an oral leukoplakia and 
called it candidal leukoplakia (Lehner 1964; Lehner 1967). Despite the confusion it 
may cause, most histopathologists prefer to use 
the term “chronic hyperplastic candidosis” 
instead of candidal leukoplakia. CHC is 
considered the most important clinical form of 
oral candidosis due to its association with the 
development of malignancy at the lesion site 
(Cawson and Lehner 1968; Bartie, Williams et al. 
2001). This tendency should prompt the oral 
diagnostician to consider an already-forming real cancer as a differential diagnosis. 
Clinical manifestations 
Chronic hyperplastic candidosis appears as discrete, raised lesions. These hyperplastic, 
sometimes nodular lesions may be speckled or homogenous and they range in size from 
small, palpable lesions to large dense plaques. They are most often white or cream-
colored (Fig. 5) but occasionally red (Fig. 6) (Appleton 2000). The red and speckled 
lesions have the clinical appearance of numerous 
white nodules on an erythematous base (Cawson 
and Lehner 1968). They occur on the buccal 
mucosa, palate, or dorsum of the tongue (Daniels, 
Schwartz et al. 1985). These lesions cannot be 
wiped off. 
Histopathology 
The clinical presentation of CHC (whether it is 
homogeneous or speckled) may reflect the histopathological picture of the lesion so the 
more nodular the lesion is, the more dysplasia the epithelium tends to show. 
Histopthaologically candidal cells, yeasts and  hyphae (Fig. 7) , are seen on the 
uppermost tissue surface, and when they invade the epithelium (hyphal and 
pseudohyphal invasion), they rarely penetrate beyond the spinous layer (Reichart, 
Philipsen et al. 1995). The lesions show hyperparakeratotic or hyperorthokeratotic 
epithelium with irregular separation and epithelial hyperplasia. There is a higher mitotic 
activity, but it is restricted to the basal and suprabasal layers of the epithelium. A 
Figure 5 showing white, cream 
colored presentation of CHC 
(Webb, Thomas et al. 1998) 
Figure 6 showing CHC in its red 
lesion form (Akpan and Morgan 
2002)  
 32
typical feature is the presence of microabscesses, 
which are collections of polymorphonuclear 
leukocytes in the epithelium. Lamina propria contains 
an inflammatory cell infiltrate composed mostly of 
lymphocytes, macrophages and plasma cells.  
Diagnosis  
To reach a precise diagnosis of oral candidosis, as 
with any other oral lesion, a thorough medical and 
dental history has to be obtained from the patient. The oral diagnostician has to conduct 
a careful clinical examination where they first inspect the lesion to see if its appearance 
matches any of the known clinical presentations of the disease. Therefore, a wide 
knowledge of oral medicine is mandatory. The next step in clinical examination is 
palpation which can indicate an important diagnostic feature i.e. whether the lesion can 
be rubbed off or not. 
If the clinical diagnosis is still provisional or doubtful, other tests are also available 
such as exfoliative cytology, culture or tissue biopsy (Epstein and Polsky 1998; 
Sherman, Prusinski et al. 2002). Exfoliative cytology is performed by scraping 
superficial cells to samples. A swab culture should be taken on the undersurface of a 
denture when denture stomatitis is suspected. If the candidal infection is thought to 
have already invaded the tissue, sampling some tissue in form of a biopsy should be 
considered (Fotos and Hellstein 1992).  Hematological screening might be useful since 
up to some 40 % of patients with oral candidosis may have some hematological 
abnormalities (Challacombe 1986).  
Management 
a) Elimination of the predisposing factors 
Once a diagnosis of oral candidosis is assured, the first line of treatment should aim to 
eliminate or alleviate any dental and/or medical factors which contribute to the 
occurrence of candidal infection in the oral cavity. The oral diagnostician may find it 
necessary to refer his/her patient, in case there is suspicion of any pertinent medical 
condition, to their physicians to seek for advice. Patient cooperation is sometimes 
crucial especially when the predisposing factors are social rather than medical, e.g. 
smoking. One of the most important factors contributing to chronic hyperplastic 
candidosis is smoking; therefore, cessation of smoking is mandatory to relieve the 
disease. Chronic atrophic candidosis is mostly associated with edentulous patients who 
Figure 7 showing histopathology of 
CHC (Sitheeque and Samaranayake 
2003) 
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wear dentures; therefore patient education and motivation to cleanse their dentures 
regularly and apply the oral hygiene measures is necessary to restore the infected 
edentulous mucosa to normalcy. If patients with acute atrophic candidosis are on broad-
spectrum antibiotics or corticosteroid, discussion with their physicians about the 
possibility of withdrawal or substitution of the medicine could resolve the problem.  
b) Antifungal treatment      
 Antifungal therapy has been used successfully in the management of oral candidosis.   
Prior to prescription of any antifungal agents, advising the patient to gargle with a 
physiological saline solution helps to decrease the oral fungal counts and thus soothe 
the associated symptoms (Appleton 2000). Pharmacological treatment of oral 
candidosis should be tailored to the individual patients according to their current 
medical status and severity of infection (Sherman, Prusinski et al. 2002). Antifungal 
agents are available in different forms (i.e. gels, ointment, creams, suspension, 
lozenges, and tablets) and the dentist should manage to select the proper form upon 
writing a prescription. Threre are many drug categories available to treat the different 
clinical presentations of candidosis, summarized as follows: 
• Polyenes: The candidal cell wall is composed of many layers, the innermost of 
which is the plasma membrane. Polyenes are potent agents which act by binding to the 
sterol part of the candidal cell membrane and disrupt its osmotic integrity leading to 
leakage of essential ions e.g. potassium and magnesium. This category includes 
nystatin and amphotericin B. Nystatin, which is of bacterial origin, is the drug of choice 
for treatment of oral candidosis. It should be prescribed cautiously in patients with 
uncontrolled diabetes or xerostomia. Recently, liposomal nystatin (Nyotran) has been 
designed where nystatin was incorporated into liposomes and it is now in late phase 
clinical trial (DiDomenico 1999). The preferred topical application of nystatin is oral 
suspension (100,000 U/ml) or pastilles (100,000 IU) for 7-14 days (Farah, Ashman et 
al. 2000). Amphotericin B can be used to treat superficial candidosis i.e. Fungizone 
(oral), or more wide-spread systemic involvement i.e. Ambisome (intravenous).  
• Antimetabolites: This group contains only one agent: flucytosine (5- 
fluorocytosine). It is candidastatic since it inhibits the candidal protein synthesis by 
replacing uracil with 5-flurouracil in fungal RNA. Its use has declined due to the 
emergence of candidal resistance (Appleton 2000).  
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• Azoles: This class includes two major categories: imidazole (e.g. clotrimazole, 
miconazole, econazole, ketoconazole) and triazole (e.g. fluconazole, itraconazole). 
Although their effect targets the plasma membrane (same as polyene), they are 
fungistatic rather than fungicidal (Wynn, Jabra-Rizk et al. 1999). Fluconazole is 
considered as the first line of treatment in many cases of candidosis but its main 
drawback is the emergence of candidal resistance.  
• Glucan synthesis inhibitors: these (e.g. caspofungin) act by inhibiting the essential 
component of the fungal cell wall, glucan. 
• Miscellaneous agents: there is only one drug available of this class of cuurent use 
i.e. griseofulvin which exerts its effect through disrupting the mitotic spindle.    
  
 Figure 8 showing a schematic diagram of C. albicans cell 
constituents as targets of antifuingal agents 
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Table 4 showing a summary of the most commonly prescribed antifungal agents for 
treating oral candidosis    
Agent name Administration (route and dose) Treatment course 
Nystatin (Mycostatin®) Oral- lozenge (200.000 U): 1X4 
       -suspension (100.000 U/ml):   
        1tsp (for 2 mins) X4 
10-14 days 
Amphotericin B 
(Fungizone®) 
Oral- tablet (10 mg): 1X4 4-6 weeks  
Clotrimazole (Mycelex®) Oral-troche (10 mg): 1X5 
       -cream (10mg/g): X4 
Troche: 14 days 
Cream: 1-8 weeks 
Miconazole (Daktarin®) 
 
Oral- gel (2%): 2.5 mlX4 Treatment continues 
1 week after 
resolution of the 
infection 
 
 
Leukoplakia (LP) 
The old official definition of leukoplakia (LP) was formulated in 1978 by the World 
Health Organization (WHO) as “A white patch or plaque that cannot be rubbed off or 
characterized clinically or pathologically as any other disease” (Sciubba 1995). WHO 
stated in a newer defintion in 1997 as a predominantly white lesion of the oral mucosa 
that cannot be characterized as any other definable lesion.  
LP can appear at any time in life, but it occurs most common in the elderly people. 
Clinically LP is a white or gray patch that develops on the tongue, inside of the cheek 
or anywhere in the mouth. The lesion may have developed slowly over weeks to 
months and be thick and slightly raised, eventually with a hardened and rough texture. 
It is usually painless, but may be sensitive to touch, heat, spicy foods, or other irritation. 
The transformation liability of LP to oral cancer is well-documented in the literature 
and is considered to have the most precancerous potential among oral lesions 
(Warnakulasuriya 2000). The highest malignant potential is seen in the nodular, 
exophytic as well as speckled forms of LP and erythroplakia (Axell, Pindborg et al. 
1996). Hansen et al., in 1985, suggested the term proliferative verrucous leukoplakia 
(PVL) for leukoplakias which tend to recur and may change to precancerous lesions 
(Hansen, Olson et al. 1985). Many studies screened the frequency of PVL and its 
progression to carcinoma in variable samples in the western countries and the results 
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ranged from 60 to 100% (Fettig, Pogrel et al. 2000; Bagan, Jimenez et al. 2003; 
Morton, Cabay et al. 2007)  
LP is thought to be a reaction of the oral mucosal membrane to chronic irritation of the 
mucous membranes. Hairy LP of the mouth is an unusual form of LP that is seen 
mostly in HIV patients (but can be found in some other immunodepressed patients).  It 
appears as fuzzy (hence the name hairy) white patches on the tongue and less 
frequently elsewhere in the mouth.  
Etiology  
• Irritation from rough teeth, fillings, or crowns, or ill-fitting dentures 
• Chronic smoking, pipe smoking, or other tobacco use  
• Alcohol abuse  
• Sun exposure to the lips  
Diagnosis  
An experienced clinician may suspect LP upon examination; however, a biopsy is 
usually necessary to rule out other causes, such as oral cancer. During the biopsy, a 
small piece of tissue from the lesion is removed to be examined histopathologically in a 
laboratory. 
Treatment  
Treatment, if needed, involves removal of the source of irritation. For example, if LP is 
caused by a rough tooth or an irregular surface on a denture or filling, the offending 
tooth should be smoothened and dental appliances repaired. If LP is caused by 
smoking, quitting of smoking is critical in relieving the lesion. 
LP is usually harmless, and lesions usually clear in a few weeks or months after the 
source of irritation has been removed. If elimination of the source of irritation is 
ineffective in reducing LP, the lesion may need to be surgically removed.  
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Host defense against oral candidosis 
Under normal conditions, the host tolerates the existence of C. albicans and other 
eventual candidal components of the oral microflora. The host safeguards itself by 
means of natural defense measures, e.g. the physical integrity of the intact epithelium, 
mucosal membrane, which serves as a natural barrier against foreign intruders 
(Marodi 1997). Thereby it acts as a selective gatekeeper allowing the passage of certain 
substances but prevents ingrowth of Candida and other microbes (Dale 2002).This 
relationship between the host and microflora is maintained and enables commensalism 
as long as the innate and adaptive immunity of the host remain competent. Once the 
host defense is compromised, opportunistic species of the microflora take benefit of it 
breaking the mutual balance by invading the host. The host tries to defend itself against 
such saprophytic opportunistic microbes by two main ways, utilizing both nonspecific 
and specific host defense.  
Nonspecific host defense (innate immunity) 
This branch of the host defense system is the first line to become engaged when a host 
encounters a pathogen. As the name indicates, it does not base its recognition 
mechanisms on learning (adaptive behavior) and immunological memory; rather, it 
senses and identifies any foreign substance, which imposes a threat to the host right 
away. Any host is naturally armed with such a protective system; therefore, it is also 
called innate immunity. Although it may utilize ligand specific receptors, these 
receptors are not drawn from a huge number of different specificities but represent 
rather broad recognition ranges. When a pathogen invades a host, the innate immunity 
serves two major tasks. It recognizes the invading organism and tries to clear it in a 
rapid but robust way. Second, it triggers a subsequent cascade whereby a more 
sophisticated machinery of the immune system (specific or adaptive) receives a danger 
signal (secondary stimulus) necessary for its activation by specific antigens (primary 
stimulus). Understandably, the innate immunity is phylogenetically ancient unlike 
adaptive immunity which is only found in vertebrates (Raj and Dentino 2002). Innate 
immune defense utilizes many mechanisms involving various molecules. There are 
some agents which have a shared task and form a bridge between innate and adaptive 
immune response e.g. defensins. To avoid repetition, the key players of the innate host 
defense will be considered under only one heading.      
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1. Toll-like receptors (TLRs) 
Toll was first discovered in Drosophila melanogaster in 1996 (Lemaitre, Nicolas et al. 
1996), its human homologues Toll-like receptors (TLRs) comprise an important family 
of receptors for the detection of microbial components of a broad variety of pathogens, 
which triggers an inflammatory host defense response and alert the adaptive arm of the 
host defense (Netea, Van der Meer et al. 2004). In mammals,  Toll has not only been 
maintained but has developed to comprise 11 identified receptors which belong to the 
family of TLRs (Takeda and Akira 2005). Structurally, TLRs are composed of an 
extracellular portion, which harbors leucine-rich repeats and an intracellular domain 
having a high degree of similarity to interleukin-1 receptor (Takeda and Akira 2004; 
Takeda and Akira 2005). Zymosan is a generic name for the polysaccharide component 
of the fungal cell wall (including yeasts). Zymosan stimulates many host cells via 
TLR2 (Underhill, Ozinsky et al. 1999). The immunostimulatory properties of zymosan 
are most probably conferred by β-glucan (Kataoka, Muta et al. 2002). In addition, 
TLR2 and TLR4 can sense C. albicans through its cell wall constituents 
phospholipomannan and mannan, respectively (Roeder, Kirschning et al. 2004). It is 
still debatable whether the morphological form of C. albicans is a determinant factor in 
excitation of or escapes from the host defense mechanisms through TLR2 and TLR4 
which could perhaps explain some apparently conflicting results (Netea, Sutmuller et 
al. 2004; Netea, Van der Meer et al. 2004; Villamon, Gozalbo et al. 2004; Villamon, 
Gozalbo et al. 2004). While epidermal keratinocytes have been found to express TLR2 
and TLR4 in response to microbial pathogens including C. albicans (Pivarcsi, Bodai et 
al. 2003), very few studies have investigated, so far, the eventual participation of such 
recently discovered structures in the immunity of the oral mucous membrane against 
candidosis.  
2. Proteins 
a) Natural antimicrobial peptides 
One of the mechanisms used by the host when it is invaded by a pathogen is production 
and / or release of substances having antimicrobial effects in response to the microbe-
host cell contact (Yang, Biragyn et al. 2002). These substances are called antimicrobial 
peptides. As the name denotes, these are small molecular-weight peptides, which are 
engaged in killing or inactivating a peptide typical spectrum of pathogenic invaders, i.e. 
viruses, bacteria or fungi (Bastian and Schafer 2001). The list of such natural defense 
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agents is already long but only the best known antifungal peptides will be presented in 
this thesis. 
? Defensins 
The discovery of defensins goes back to the time when a class of peptides, found to 
have antimicrobial properties, was isolated from macrophages of rabbit lung (Selsted, 
Brown et al. 1983). A couple of years later, similar peptides were found in human 
neutrophils and therein the term defensin was coined (Ganz, Selsted et al. 1985). 
Defensins are cysteine-rich antimicrobial peptides containing three pairs of disulfide 
bridges (Lehrer and Ganz 1999). They have a molecular-weight of 2000-6000 Da and 
their amphipathic properties allow hydrophilic, hydrophobic and cationic clustering 
(Marshall 2004). There are three classes of defensins: alpha (α), beta (β) and theta (θ), 
of which only the first two exist in humans (Izadpanah and Gallo 2005). Alpha-
defensins are composed of 29-35 amino acid residues and they are shorter than β-
defensins, whose amino acid number ranges from 38 to 42 (Raj and Dentino 2002). 
These defensins have different locations of cysteine residues and disulfide motifs. 
Alpha-defensins are subcategorized into six types designated from 1 to 6. The first four 
subclasses (1 to 4) are produced by polymorphonuclear leukocytes (therefore, they are 
referred to as Human Neutrophil Peptide or HNP) while the last two are produced by 
Paneth cells of the intestine and the female genitourinary tract (Quayle, Porter et al. 
1998). The four types of  β-defensins are produced by epidermal keratinocytes of the 
skin and epithelial cells of the mucous membranes of the mouth, gastrointestinal and 
genitourinary tracts (Raj and Dentino 2002).  
Microbial membranes are the main targets of the microbicidal effects of defensins. 
Because of their positive charge, defensin peptides interact with the negatively charged 
components or pathogen-associated molecular structures of the microbial membranes. 
This antimicrobial protein-microbial membrane interaction results in disruption of the 
latter and leakage of the microbial cell membrane leading to osmotic rupture and death 
of the microbial cell (Weinberg, Krisanaprakornkit et al. 1998).  
Along with their obvious role in innate immunity, α- and β-defensins are also linked to 
the adaptive immune response. They augment the adaptive immune response of the host 
through recruitment of inflammatory cells to the site of the microbial invasion. Alpha-
defensins act directly as chemotactic agents to recruit CD8 and CD4 T cells as well as 
immature dendritic cells. They also stimulate release of the chemokine interleukin 8 by 
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epithelial cells which attracts neutrophils to the site of infection (Van Wetering, 
Mannesse-Lazeroms et al. 1997; Zasloff 2002).  
? Histatins 
Histatins, which are small histidine-rich cationic peptides, comprise an important group 
of the antimicrobial peptides of saliva. They are secreted by the parotid and 
submandibular salivary glands and their molecular size ranges from 7-38 amino acids  
(Kavanagh and Dowd 2004). The proteolytic degradation of the products of the two 
histatin genes (HIS1 and HIS2) results in the formation of at least 12 histatin fragments 
in human saliva, of which histatin 5 is the most active form against C. albicans (Xu, 
Levitz et al. 1991; Ruissen, Groenink et al. 2002). Histatin 5 tends to retard the 
transition of C. albicans from the unicellular to the fungal form, a step necessary for the 
tissue invasion and penetration (Cannon, Holmes et al. 1995). It has been postulated 
that histatin 5, as all other cationic antimicrobial peptides, disrupts the osmotic integrity 
of C. albicans by creating permanent pores in its cell membrane. Consequently, the 
membrane loses its ability to control the passage of ions in and out of the 
microorganism leading to its demise. Also other antifungal mechanisms have been 
reported to histatin 5, e.g. binding to the fungal mitochondria which cause release of 
cellular ATP out of the cell so that the candidal cell becomes depleted of its energy 
supply (Helmerhorst, Breeuwer et al. 1999), and generation of lethal reactive oxygen 
species (Helmerhorst, Troxler et al. 2001). The ability of histatin 5 to kill azole-
resistant fungi has made it a topic of intensive research as a potential synthetic 
chemotherapeutic antifungal agent (Tsai and Bobek 1997). 
? Protegrins 
Protegrins belong to a larger group of cathelin-containing antimicrobial peptides called 
cathelicidins (Zanetti, Gennaro et al. 1995). Protegrins are small (2 kDa) as they 
contain only 16 to18 amino acids particularly cysteine and arginine. They were first 
isolated from porcine leukocytes (Fahrner, Dieckmann et al. 1996) and they occur in 
five sequential types (PG-1 to PG-5).  
b) Chemokines and cytokines  
Chemokines are small secreted proteins whose main function is to attract leukocytes to 
move in a specific direction, along the gradient of the chemokine concentration. In 
other words, chemokines are chemotactic cytokines (hence their name, chemo for 
chemotaxis and kine for cytokine) (Baggiolini 2001). Cytokines are regulatory proteins, 
such as the interleukins and lymphokines that are released by cells of the immune 
 41
system and act as intercellular mediators in the generation of an immune response. 
Thus, cytokine is a more general term than chemokine, which also participate in 
intercellular communications in a well defined and narrow area. Structurally, 
chemokines form a family of structurally related glycoproteins with potent leukocyte 
chemotactic and activating properties. The molecular weight of chemokines ranges 
from 8 to10 kD and they are 70 to 90 amino acids in length, having 20 to 70% 
homologies in their amino acid sequences (Luster 1998). Most of them fit into two 
subfamilies with four cysteine residues. These subfamilies segregate based on whether 
the two amino terminal cysteine residues are immediately adjacent to each other (cc 
chemokines) or separated by one amino acid (cxc or alpha chemokines). The CXC 
group includes molecules such as interleukin-8 and platelet factor 4 most of them being 
chemoattractants for neutrophils. Examples of the CC group (beta chemokines) include 
eotaxin and monocyte chemoattractant protein-3, and such chemokines generally attract 
monocytes, lymphocytes, basophils, and eosinophils (Luster 1998). There are also two 
other small subgroups. The C group has one member (lymphotactin) which lacks one of 
the cysteines in the four-cysteine motif, but shares homology at its carboxyl terminus 
with the C-C chemokines. The C chemokine seems to be specific for lymphocyte. The 
fourth subgroup is the C-X3-C subgroup. The C-X3-C chemokine (e.g. fractalkine / 
neurotactin) has three amino acid residues between the first two cysteine amino acids. It 
is tethered directly to the cell membrane via a long mucin stalk and induces both 
adhesion and migration of leukocytes. 
Chemokines can also be classified to either inflammatory or homing (homeostatic): 
inflammatory chemokines are widely distributed in most tissues and their expression is 
triggered by inflammatory stimuli, while homing chemokines are constitutively 
expressed within lymphoid tissues (Baggiolini 2000). Chemokines exert their effects, as 
any protein ligand, through receptors. This chemokine-receptor binding may, in the 
future, be employed to provide a successful chemotherapy of certain drastic diseases, 
e.g. AIDS. This is exemplified by the finding that the HIV antigen gp120 recognizes 
overlapping receptors epitopes to which chemokines can bind (Baggiolini 1998). 
Chemokines act via many seven-transmembrane-domain receptors, two of which, 
CXCR1 (IL-8RA) and CXCR2 (IL-8RB), are for interleukin-8.  
In this thesis, only two cytokines, IL-8 and RANKL, will be discussed  
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a) Interleukin-8 (IL-8)    
Interleukin-8 (IL-8) is a chemotactic cytokine which attracts leukocytes and stimulates 
monocyte adherence (Lane, Lore et al. 2001). The main cell target for the chemotactic 
effect of IL-8 is neutrophil. The chemotactic effect of IL-8 results in recruitment and 
transmigration of neutrophils across the microvasculature to the site of inflammation 
(Schall and Bacon 1994). IL-8 is also a chemoattractant for T lymphocytes (Larsen, 
Anderson et al. 1989) and basophils. IL-8 was also referred to as neutrophil 
chemotactic factor (NCF), neutrophil activating factor (NAF) (Walz, Peveri et al. 
1987), neutrophil activating protein (NAP) , monocyte-derived neutrophil chemotactic 
factor (MDNCF) (Yoshimura, Matsushima et al. 1987), T cell chemotactic factor 
(TCF), granulocyte chemotactic protein (GCP) and leukocyte adhesion inhibitor (Yang, 
Huang et al.). It is released by several cell types including monocytes, macrophages, 
neutrophils, T-lymphocytes, fibroblasts, endothelial cells, and epithelial cells after an 
inflammatory stimulus, e.g. IL-1, TNF, LPS, or viruses (Yoshimura, Matsushima et al. 
1987; Peveri, Walz et al. 1988; Strieter, Kunkel et al. 1988; Strieter, Phan et al. 1989; 
Palter, Mulayim et al. 2001). IL-8 belongs to the CXC subfamily of chemokines, is a 
member of the beta-thromboglobulin superfamily and structurally related to platelet 
factor 4. IL-8 may play an important role in the progression of many cancerous 
diseases, e.g. melanoma, breast cancer and lung cancer (Reed and Purohit 1997; 
Poppenborg, Knupfer et al. 1999; Penson, Kronish et al. 2000). It was found that IL-8 is 
produced by fibroblasts in the dental pulp when it is stimulated with substance P (Park, 
Hsiao et al. 2004) or black-pigmented Bacteroids (Yang, Huang et al. 2003). IL-8 
induces its chemotactic effect via two receptors: CXCR1 and CXCR2, also known as 
IL-8RA and IL-8RB, respectively (Murphy and Tiffany 1991). Both receptors are 
found plentifully on neutrophils while they are expressed less on monocytes and 
myeloid cell lines (Sprenger, Lloyd et al. 1994). Beside its chemotactic effect and 
recruitment of neutrophils to the site of inflammation, IL-8 has been claimed to trigger 
the oxidative burst response in those cells (Baldwin, Weber et al. 1991), thereby aiding 
their microbicidal efficacy.  
In the oral mucosa, IL-8 plays a major role in combating pathogens such as C. albicans 
through recruitment of neutrophils and lymphocytes to the site of infection.    
b) RANKL 
 The cytokine receptor activator of nuclear factor κB ligand (RANKL) is a membrane-
bound ligand that belongs to the tumor necrosis factor family (Hofbauer and Heufelder 
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2001), which bestows RANKL an other synonym: TRANCE (TNF-related activation-
induced cytokine). It is a protein consisting of 316 amino acids with a molecular mass 
of 35 kDa (Yasuda, Shima et al. 1998). RANKL is produced by osteoblastic lineage 
cells (Gori, Hofbauer et al. 2000), fibroblasts (Mandelin, Li et al. 2003), immune cells 
(Anderson, Maraskovsky et al. 1997) and some cancer cells (Nagai, Kyakumoto et al. 
2000). The main function of RANKL is to orchestrate formation, maturation and 
activation of osteoclast (Jeziorska, McCollum et al. 1998; Liu, Xu et al. 2003); 
therefore, RANKL was also known as osteoclast differentiation factor (ODF). The 
inductive action of RANKL on osteoclast progenitors is mediated through binding to its 
receptor RANK. Binding of RANKL to RANK is counteracted by a decoy receptor 
called osteoprotegerin (OPG), which is the reason why RANKL was also called 
osteoprotegerin ligand (OPGL). The neutralizing effect of OPG on RANKL-RANK 
interaction was based on the observation that OPG (-/-) knockout mice develop 
osteoporosis and arterial calcification of aorta and renal arteries (Schoppet, Preissner et 
al. 2002). RANKL can occur in three forms: either as a cell-bound, truncated or 
secreted (Hofbauer, Shui et al. 2001). The role of RANKL in bone metabolism is 
manifested in many pathological conditions, e.g. rheumatic disease (Haynes, Barg et al. 
2003), atherosclerosis (Collin-Osdoby 2004), cancers such as multiple myeloma 
(Farrugia, Atkins et al. 2003) and prostate cancer (Lynch, Hikosaka et al. 2005), 
periodontitis (Crotti, Smith et al. 2003; Liu, Xu et al. 2003) and aseptic bone loss in 
total hip replacement (Gehrke, Sers et al. 2003). The expression of RANKL is 
upregulated by some factors which have been associated with bone resorption, e.g. 
glucocorticoids, interleukins (IL-1, IL-6, IL-11 and IL-17), TNFα and PTH (Kong and 
Penninger 2000). Another important role of RANKL, beside its osteoclastogenetic 
effect, is immunity. The fact that activated CD4+ and CD8+ T lymphocytes display 
RANKL in lymphoid structures, such as lymph nodes, Peyer’s intestinal patches and 
thymus (Lacey, Timms et al. 1998), and that RANK is expressed by dendritic cells 
evoked the concept of RANKL contributing to immunological processes. So far, no 
analytical study has been conducted to assess the role of RANKL and RANK 
interaction in an infectious disease, let alone candidosis. 
3. Cells 
Along with the cytokines and the natural antimicrobial peptides, there are certain cells 
which belong to the innate immune system and aid in extinguishing the infectivity of 
pathogens.  
 44
Such cells include phagocytic cells (macrophages and neutrophils) that can engulf 
(phagocytose) foreign substances. Macrophages are thought to mature continuously 
from circulating monocytes. 
Phagocytic cells respond to the chemotactic stimuli by carrying out three main steps 
which guide their migration towards the chemotactic stimulus. These steps are 
margination and rolling, adhesion and transmigration, and then the final migration 
towards the site of inflammation. The journey of the phagocytic cells to their destiny is 
guided by chemotaxis. Chemotaxis is the process by which phagocytes are attracted to 
where the microorganisms are located by means of chemotactic stimuli such as 
microbial products, complement, damaged cells and white blood cell fragments. 
Chemotaxis is followed by a direct contact of the phagocyte with the microorganisms. 
This intimate adhesion is enhanced by opsonization, where protein components (called 
opsonins) coat the surface of the pathogen. This is followed by ingestion, in which the 
phagocyte extends projections, or pseudopods that engulf the foreign organism. Finally, 
the pathogenic microbe in the phagosome fuses with a lysosome and is digested by 
enzymes in the phagolysosome, a process involving also reactive oxygen species. Many 
important cells are involved in the host immune defense against infection such as 
neutrophils, dendritic cell and mast cells. 
a) Neutrophil 
The first phagocyte a pathogen is likely to encounter is a neutrophil. A neutrophil is a 
type of white blood cell which plays major early role in the cellular innate immune 
response against foreign invaders. Neutrophils are produced in the bone marrow at a 
rate of 1011 cells per day, and then circulate around the blood stream as mature cells for 
approximately ten hours before migrating into the peripheral tissue pools, where they 
reside for their 1 to 2 day long living period (Smith 1994). After that neutrophils 
undergo apoptosis (Savill, Fadok et al. 1993). It is thought that the short life span of 
neutrophils might be due to their involvement in the maintenance of body homeostasis 
which renders them susceptible to cellular stress (Smith 1994), to minimize propagation 
of those pathogens that parasitize phagocytes, and to diminish the damaging effects of 
the antimicrobial products on the host tissues.  
Neutrophils constitute 50 to 60% of the total population of leukocytes (Smith 1994). 
Like other phagocytes, they are recruited to the tissue site where the noxious substance 
is located. Once there, they approach the invading stimulus and display a variety of 
antimicrobial processes, e.g. elaboration of natural antimicrobial peptides, enzymes 
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(e.g. peroxidase, hydrolytic enzymes), and eventually engulf it. Because of their 
peculiar nuclear morphology (the nucleus is termed segmented or polymorphonuclear), 
neutrophils belong to the polymorphonuclear leukocytes (PMLs) (Huizinga, Roos et al. 
1990). They contain granules and are also known as granulocytes. These cytoplasmic 
granules are tiny vesicles containing enzymes that help the cell to efficiently perform its 
microbicidal function. Neutrophils utilize two major microbicidal mechanisms, namely 
oxidative and enzymatic processes. In this way, it kills and digests microorganisms that 
it has already engulfed by phagocytosis. Degranulation process of the cytoplasmic 
granules of neutrophils also causes an extracellular release of its destructive mediators. 
Neutrophils are active phagocytes, capable of only one phagocytic event, expending all 
of their glucose reserves in an extremely vigorous respiratory burst. The respiratory 
burst involves activation of an NADPH oxidase enzyme, which produces large 
quantities of superoxide converted to other reactive oxygen species. Beside their role as 
direct scavengers of toxic substances in the body, neutrophils can also aid in the 
regulation of the inflammatory process by secreting of humoral mediators such as 
cytokines, e.g. TNF-α (Lloyd and Oppenheim 1992), IL-1β (Palma, Cassone et al. 
1992), IL-6 (Melani, Mattia et al. 1993) and IL-8 (Strieter, Kasahara et al. 1990). Being 
highly motile, neutrophils quickly congregate at the site of infection, dragged by 
cytokines expressed by cells at the site of action, e.g. activated endothelium, mast cells 
and macrophages. Neutrophils are also under normal circumstances produced in huge 
numbers, but this may increase as much as 10-fold in response to an infection 
(Cannistra and Griffin 1988). 
In candidosis, neutrophils play a major role in combating the pathogen C. albicans by 
expressing either candidastatic and/or candidacidal mechanisms. Neutrophils contain 
calprotectin in their cytoplasm which inhibits the growth of the fungus without killing it 
(Sohnle and Collins-Lech 1990). Neutrophils can eliminate the fungal pathogen from 
the host by producing candidacidal proteins, e.g. HNP 1-4. The hyphal and 
pseudohyphal forms of the organism can be engulfed and damaged by neutrophils 
through oxidative mechanisms (Diamond, Clark et al. 1980). The importance of 
neutrophils in defending the host against C. albicans is supported by the fact that 
candidal infection predominates in patients with chronic granulomatous disease in 
which leukocytes suffer from NADPH oxidase deficiency (Kim, Rodey et al. 1969).  
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b) Dendritic cells 
Dendritic cells (DCs) belong to a class of cells known as antigen presenting cells 
(APCs). They are derived from haematopoietic stem cells in the bone marrow and were 
first identified in 1973 (Steinman and Cohn 1973; Scimone, Lutzky et al. 2005). 
Possibly excluding the brain, testes and cartilage, DCs patrol almost all other tissues of 
the body (Cutler, Jotwani et al. 2001). They are found most commonly in places with 
direct contact with the environment, in skin and mucous membranes where they serve 
as sentinels against ingress of pathogens. In humans, DCs are classified into three 
subsets. Two are myeloid cells, namely Langerhans cells and dermal DCs (both of 
which can be generated in vitro from human cord blood CD34+ hemopoietic 
progenitors) (de Saint-Vis, Fugier-Vivier et al. 1998) and the third one is lymphoid DCs 
(Cutler, Jotwani et al. 2001). When they circulate in the blood, DCs are 
indistinguishable from monocytes but when they reside in peripheral tissues, e.g. skin 
and mucosa, they develop long spiky projections called dendrites, from which their 
name is derived (Cutler and Jotwani 2004). DCs are considered to represent an 
important link between innate and adaptive immune responses (Palucka and 
Banchereau 1999). In the mucous membranes and epidermis, DCs are present as 
Langerhans cells (LCs), while in the dermis they are known as dermal DCs. Despite 
their old discovery in 1868 by Paul Langerhans (after whom LCs are named), LCs were 
categorized as a class of DCs very recently, in 1979 (Palucka and Banchereau 2006). 
LCs are found above the basal layer in skin and mucosal surfaces of the mouth, nose, 
gastrointestinal tract and genitourinary tract (Jotwani and Cutler 2003). The primary 
function of LCs (and other DCs) is to control the potential pathogen entry sites and 
hence they are considered as immunosurveillant cells. Having not exposed to an antigen 
yet, LCs remain in a resting and immature state but characterized by high endocytotic 
activity. When an antigen is encountered, e.g. C. albicans, LCs capture it and actively 
internalize it by phagocytosis (Ramachandra, Chu et al. 1999). The manner of 
phagocytosis depends on the morphological form of the fungal part being engulfed. 
LCs engulf yeasts through coiling phagocytosis while zipper-like mechanism is the 
prevalent phagocytosis type for hyphae (Montagnoli, Bacci et al. 2001). In the 
cytoplasmic vacuolar compartments, LCs process the fungal cell, degrade it into 
fragments and then associate it with major histocompatibility complex-antigen (MHC I 
or II, depending on the antigen) (Romagnoli, Nisini et al. 2004). After the LCs  have 
packaged the antigen with MHC, they extrude the whole complex to the cell surface for 
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recognition by T cells (Adams, O'Neill et al. 2005). If antigen-specific T cells are 
encountered, a response ensues and LCs transform to the active, mature form, they 
migrate via blood or lymphatic vessels to the regional lymph nodes where they interact 
with naïve T cells (Banchereau and Steinman 1998). This interaction is mediated 
through upregulation of certain cell surface receptors, e.g. CD80 and CD86, which aid 
in priming and enhancing the T lymphocytes.   
c) Mast Cells 
Paul Ehrlich, when still a medical student in 1878, was the first to describe mast cells 
whose large size and metachromatic granular appearance led him to the mistaken belief 
that they were either well-fed or feeding the surrounding tissues, and therefore gave 
them the name ‘mastzellen’ which means “feeding cells”. Mast cells develop in the 
bone marrow from CD34+ pluripotent stem cells. Being still immature, mast cells 
circulate in the blood and lymphatics to home to tissues where they undergo maturation 
by a locally-produced growth factor (Prussin and Metcalfe 2003). Throughout the 
human body mast cells (infrequently known as mastocytes) are found in connective 
tissues and submucosal areas (Kelley, Chi et al. 2000), preferably around the blood 
vessels and beneath the epithelium (Church and Levi-Schaffer 1997). The role of mast 
cells in the pathogenesis of many human diseases e.g. atherosclerosis, has become 
strongly evident (Kovanen 1995). Although some researchers prefer to classify mast 
cells according to their location into mucosal and connective tissue mast cells 
(Gemmell, Carter et al. 2004), the granular content of mast cells remains the prominent 
criterion for categorizing them into mast cell tryptase (MCT) and mast cell tryptase and 
chymase (MCTC). As the name denotes, MCT contains tryptase in their granules and are 
found most abundantly in the respiratory and intestinal mucosa and conjunctiva (Irani, 
Schechter et al. 1986). On the other hand, MCTC contains both tryptase and chymase 
and predominate in the skin and submucosa of the small intestine and subepithelial area 
of the conjunctiva (Irani, Bradford et al. 1989). Mast cells are known best for their 
participation in allergy through their expression of high affinity receptor (FcεRI) for 
immunoglobulin E. The prominent location of mast cells in the vicinity of blood vessels 
most probably dictates their primary function in the regulation of the vascular muscle 
tone in the inflammatory process. Beside tryptase and chymase, mast cell granules 
contain and / or rapidly produce an array of active mediators and cytokines, e.g. 
histamine, heparin, carboxypeptidase, prostaglandins (PGD2, PGE2), thromoxanes, IL-
4, TNF-α, RANKL and growth factors (Kelley, Chi et al. 2000). When mast cells are 
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stimulated, they elaborate their granular contents to the extracellular environment by 
exocytosis, a process known as degranulation. Mast cells are considered an integral part 
of the immune system. In tissues, mast cells remain in close proximity to T cells 
(Mekori and Metcalfe 1999) since the former has the ability to engulf and process 
antigens, and present them to the latter, thereby aiding in the initiation of an adaptive 
immune response (Malaviya, Twesten et al. 1996). Release of IL-16 by mast cells is 
thought to be an important explanation for the presence of CD4+ T cells at sites of mast 
cell activation (Rumsaeng, Cruikshank et al. 1997), since IL-16 is a preferential 
chemoattractant for CD4+ T cells (Center, Kornfeld et al. 1996). Although mast cells 
have been shown to be involved in the immune defense against many bacteria, e.g. K. 
pneumoniae, there is no study; so far, attempting to clarify whether mast cells play a 
role in the host defense against candidal infection. 
Specific host defense (acquired immunity)  
The second category of the immune system is called specific, acquired or adaptive 
immunity. As the name suggests, this branch of the host defense is directed against the 
particular and specific pathogens which have succeeded partially or totally in 
overwhelming the shields of the innate immune armory system. It takes days for the 
specific immunity to recruit, activate and expand the antigen-specific lymphocytes, 
which is much longer than it takes to mount the immediate innate defense response. 
Therefore, the specific host response is not effective in eliminating infections in their 
early stages and its major role comes to play in cases of long lasting infections. The 
specific host defense is divided into two major sections through which it exerts its 
mechanisms: cell-mediated T cells and humoral (antibodies) immunity.    
1. Cell-mediated immunity   
The cellular arm of the specific immune defense is formed of T lymphocytes, which is 
abbreviated as T cells. This subclass of white blood cells originates in the bone marrow 
from pluripotent haematopoietic stem cells, and the newly-formed cells then circulate 
through the thymus gland (the letter T which represents this class of lymphocytes is 
derived from thymus) and differentiate to thymocytes (Vallejo, Davila et al. 2004). 
They are usually divided into two major subsets that are functionally and 
phenotypically different, cytotoxic T cells (CD8+) and helper T cells (CD4+) (Germain 
2003). Cytotoxic T cells (sometimes called killer/suppressor, CD8+) are important in 
the direct destruction of certain tumor cells, virally infected cells and sometimes 
parasites. Most CD8+ T cells recognize antigens only when they are bound to the MHC 
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class I (MHC-I) molecules. The other category of T cells is CD4+ (helper) T cells which 
constitute a pertinent coordinator of immune regulation. Their main function is to 
augment or potentiate the immune responses by secretion of specialized factors or 
cytokines, which activate other white blood cells to fight the infection. Most CD4+ T 
cells recognize antigens associated with MHC II (Siu 2001). There are two subsets of 
T-helper cells: Th1 cells which, through their secretion of IL-2 and INF-γ, enhance cell-
mediated immune response and in the same time inhibit the other subset of T-helper 
cells, the Th2 cells. Th2 cells are engaged in minimizing cell-mediated immune 
response through secretion of certain cytokines such as IL-4 and IL-10. Both types of T 
cells can be found throughout the body. They often depend on the secondary lymphoid 
organs, the lymph nodes and spleen, as sites where activation occurs, but they are also 
found in other tissues of the body, most conspicuously in the mucosal-associated 
lymphatic tissue in intestinal and reproductive tracts, but also in liver, lung and blood.  
T cells are responsible for cell-mediated immunity which is of paramount importance in 
the defense against viral, bacterial and fungal infections. T cells also aid B lymphocytes 
to produce antibodies, recognize and reject foreign tissues due to their histocompatible 
tissue type (or actually MHC molecules). T lymphocytes first have to find their way to 
the site of infection. Once there, they are exposed to an antigen so that the antigen-
specific T cells divide rapidly and produce large numbers of new T cells sensitized to 
the various epitopes of the pathogen specific set of antigens. T lymphocytes play a 
central role in control of the acquired immune response and, furthermore, serve as 
crucial effectors through antigen specific cytotoxic activity  
As to candidal infections, cell-mediated immunity is necessary in the successful 
defense of the host against candidosis, especially on mucosal membranes (Fidel 2002). 
This is based on the experimental observation that T cell-deficient mice fail to resist 
gastrointestinal candidosis whereas those mice with deficient phagocytic capability and 
normal T cell function readily cleared the infection (Balish, Filutowicz et al. 1990). Th1 
response in particular is the branch of cell-mediated immunity which provides 
protection against candidosis, while Th2 pathway would lead to attenuation of the Th1 
response (Romani, Mocci et al. 1991).  
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2. Humoral Immunity 
Humoral immunity is the second branch of the adaptive immune response. It pertains to 
antibody production and all the accessory processes involved, e.g. Th2 activation and 
cytokine production, germinal center formation and isotype switching, affinity 
maturation and memory cell generation. The main functions of antibodies are pathogen 
and toxin neutralization, classical complement activation, opsonin promotion of 
phagocytosis, and pathogen elimination (Cooper 1985; Edelman 1991).  
The process of antibody production, which is T-cell dependent, is the responsibility of a 
class of lymphocytes called B cells (B refers to Bursa of Fabricius in birds, necessary 
for the maturation of B cells), which need two signals to initiate the humoral immune 
response (Gulbranson-Judge and MacLennan 1996). With a T-dependent antigen, the 
first signal comes from antigen-mediated cross-linking of B cell receptors and the 
second signal derives from the Th2 cells. First, cross-linking of the T-dependent 
antigen on B cell ensues, followed by presentation of that antigen associated with MHC 
II to Th2 cells, which then provide co-stimulation to trigger B cell proliferation and 
differentiation into plasma cells (Parker 1993; Baker, Gagnon et al. 2000). Cytokines, 
predominantly IL-4, IL-5, and IL-6, stimulate the B cells to divide and differentiate into 
antibody-secreting plasma cells. A few activated B cells differentiate into short-lived 
plasma cells that migrate directly to the medullary cords and begin secreting IgM and 
later IgG. Isotype switching to IgG, IgA, and IgE and memory cell generation occur in 
response to T-dependent antigens and cytokines (Jumper, Splawski et al. 1994). In a 
primary immune response, IgM is secreted before isotype switching occurs and is the 
predominant isotype produced. Each antibody isotype has its specific effector functions 
in humoral immunity.  
Plasma cells are antibody-producing cells that no longer divide in response to antigen. 
They are larger than B cells and have more ribosomes, endoplasmic reticulum, and 
Golgi complexes. Some plasma cells survive only a few weeks, while others continue 
to produce antibody for longer periods, providing rapid protection against an eventual 
re-infection. Other B cells become memory cells with high avidity antigen-specific B-
cell receptors, which can be rapidly re-stimulated by antigen and are present in higher 
frequency than the naïve resting B cells were before the infection and antigen-driven 
oligoclonal expansion of the antigen-specific B cell clones. 
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There are five different antibody isotypes, IgG, IgM, IgA, IgE, and IgD. All theses 
isotypes seem to have unique features and different implications in the humoral 
immune response (Han, Mou et al. 1995). When microbes enter the body through the 
epithelia of the oral mucosa, for example, they may begin replicating locally or get into 
the circulation and move throughout the body. The Fc regions of the pentavalent IgM, 
which is secreted first in a primary immune response, allow them to aggregate antigens 
present at relatively high concentration and subsequently bind to Fc receptors of 
professional phagocytes to be phagocytozed in e.g. splenic and liver sinusoids. Because 
IgM is so large, it cannot enter the tissues very efficiently; but it is effective in 
controlling pathogens in the circulation. Once isotype switching occurs, IgG with the 
same antigen specificity starts to predominate in serum and in tissues. IgG both 
neutralizes pathogens and their toxins and opsonizes them for phagocytosis by 
neutrophils and macrophages (Robbins and Robbins 1986). Interestingly, only IgG 
seems to be able to cross the placenta and impart immunity to the developing fetus. IgG 
can also activate complement on the pathogen surface once concentrations are high 
enough for two IgG molecules to bind to nearby epitopes. IgA is the predominant 
antibody that is secreted across epithelial cells of the respiratory, digestive and genital 
tracts to block pathogen entry into the body (Robbins and Robbins 1986). IgE binds to 
FcεRI on mast cells surrounding the blood vessels throughout the body. When a 
pathogen binds and cross-links the mast cell surface IgE, the mast cell immediately 
releases inflammatory mediators that trigger coughing, sneezing or vomiting to expel 
pathogens from the body. 
Antibodies against candidal antigens are found in the sera of most people (Lehner, 
Buckley et al. 1972), being higher in patients with chronic mucocutaneous candidosis 
in whom the assessed antibodies seemed to be directed against the cell wall component 
mannan (Lehner, Wilton et al. 1972). Nevertheless, the role of humoral immunity in the 
defense process against mucosal or systemic candidosis is still questionable (Fidel 
2002). There are reports about children having defective B cell functions, either 
congenital or acquired, who did not show any susceptibility to candidal infection 
(Rogers and Balish 1980). It is obvious that antibodies per se cannot exert any 
candidastatic or candidacidal activities; rather they contribute by acting as opsonins for 
neutrophils and macrophages at the site of infection.  
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AIMS OF THE STUDY 
 
1. To assess and clarify the presence of α-defensin-1, its localization and eventual 
immunohistopathological signs of its participation in the host response against 
chronic candidal stimulus in CHC compared with candida-negative leukoplakia 
lesions.  
2. When performing immunohistochemical staining of RANKL in CHC samples, 
we found accidentally that mast cells form a source of RANKL; therefore we 
aimed to confirm this pioneering discovery in atherosclerotic samples. We 
chose atherosclerosis because mast cells have a well-established role in the 
pathogenesis of the disease.  
3. To evaluate the histopathological distribution of CD1a Langerhans cells in CHC 
compared with leukoplakia and healthy controls, and whether the number of 
these RANK-positive antigen-specific cells correlates with that of RANKL-
producing mast cells.  
4. To investigate the contribution of the chemokine IL-8 and its receptor IL-8 RA 
in the host defense against C. albicans and check if there is any 
immunohistopathological signs of their involvement in CHC compared with 
healthy controls.  
5. To study what TLRs (TLR1-9) plays roles in the immune response of the host 
against C. albicans by comparison of the CHC lesions with leukoplakia and 
healthy mucosa and by studying the effect of those candidal PAMPs on mucosal 
epithelial cells which differed between CHC and comparators.  
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MATERIALS AND METHODS 
 
Criteria for patient selection 
a) For patients of CHC & LP 
The local Ethical committee approved the study protocol. Ten biopsy samples of oral 
mucosal lesions were obtained from patients with chronic hyperplastic candidosis 
(n=10) and the same number from patients with leukoplakia (n=10) undergoing 
examination of mucosal lesions (Table 5). Histopathology of both disease entities 
disclosed their corresponding typical features. Periodic Acid Schiff (PAS) staining of 
the biopsy samples and/or fungal culture of saliva samples on Dentocult CA® culture 
medium (Orion Diagnostica, Espoo, Finland) were used to confirm or exclude the 
fungal infection. Five biopsy samples were recruited from healthy individuals 
undergoing dental procedure to serve as controls.  
b) For patients of atherosclerosis 
Coronary artery samples were collected from left anterior descending coronary arteries 
from five unselected patients autopsied for medicolegal reasons. All coronary segments 
contained a large confluent core of extracellular lipid. The local Ethical committee 
approved the study protocol.  
Biopsies: processing and storage 
All biopsies (CHC, LP, healthy controls and atherosclerosis) were fixed in formalin 
(10% phosphate buffered formalin, pH 7) and stored at 4+°C. After fixation, the tissue 
biopsies were dehydrated by first using graded ethanol solutions, then graded xylene 
solutions followed by liquid paraffin. The wax was allowed to solidify, forming blocks 
into which the tissues were embedded in cassettes. Out of these paraffin blocks, 6 µm 
and 4 µm (for study II) thick sections were cut and mounted on objective glass slides, 
which were then stored till immunostaining was performed. The modern paraffin is 
typically a mixture of paraffin wax and resin and it provides excellent morphological 
detail and resolution.  
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Table 5. Clinical and demographic data of the patients with chronic hyperplastic  
candidosis (CHC), leukoplakia (LP) and healthy controls (HC). 
  
M = Male, F =Female
Number Gender Age Location of the 
lesion 
Clinical 
presentation 
Additional 
Information 
1 CHC M 59 Tongue Diffuse 
keratinization 
Heavy smoker 
2 CHC F 45 Tongue Red/white lesion Painful 
3 CHC F 59 Tongue Homogenous  
4 CHC F 67 Palate Verrucous Prosthesis 
5 CHC F 55 Cheek/Commissures Hyperplastic Heavy smoker 
6 CHC F 53 Tongue Nodular Sharp tooth edge 
7 CHC M 44 Tongue Ulcerative  
8 CHC M 53 Palate Verrucous  
9 CHC F 81 Cheek Papular 
leukoplakia 
Carcinoma of tongue 
10CHC F 85 Tongue Hyperplastic  
1 LP F 51 Alveolar ridge White patch  
2 LP F 55 Tongue White patch  
3 LP F 52 Cheek Striated patch  
4 LP F 73 Floor of the mouth Exophytic Prosthesis, heavy 
smoker 
5 LP F 66 Palate Striated   
6 LP F 64 Floor of the mouth Homogenous  
7 LP F 50 Alveolar ridge Exophytic  
8 LP F 48 Cheek Striated  
9 LP F 84 Alveolar ridge Exophytic, 
pigmented 
Prosthesis 
10 LP M 49 Alveolar ridge White patch  
Number Gender Age Location of the sample Reason presenting patient to 
the clinic (no inflammation) 
1 HC F 56 Upper left sulcular mucosa Resection of left upper incisor  
2 HC F 57 Upper left sulcular mucosa Wisdom tooth operation 
3 HC F 44 Lower right sulcular mucosa Orthodontic treatment 
4 HC M 32 Upper right sulcular mucosa Check-up  
5 HC F 25 Upper posterior vestibular 
mucosa 
Check up 
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Histological Staining 
a) Periodic acid Schiff staining 
Periodic acid-Schiff (PAS) staining of sections from lesions of both chronic 
hyperplastic candidosis (CHC) and leukoplakia was used to confirm or exclude the 
presence of candidal hyphae. It is also used for the demonstration of glycogen and 
neutral mucins. PAS stain consists of 1% Periodic acid and Schiff's reagent (Basic 
Fuchsin, Potassium metabisulphite, Hydrochloric acid, Deactivated Charcoal and 
Distilled water). 
Procedure 
Following deparaffinization sections were 1) immersed in distilled water, 2) treated 
with 0.5% periodic acid for 5 minutes at room temperature, 3) washed well in distilled 
water, 4) treated with Schiff's reagent for 20 minutes, 5) washed in running tap water 
for 10 minutes, 6) counterstained with Mayer's Haematoxylin for 5 minutes and 7) 
dehydrated in alcohol, cleared in xylene and mounted in Diatex. 
b) Immunohistochemistry  
Immunohistochemistry is a method used to detect antigens in tissues using antibodies, 
and it was the main method used in all projects of this study. 
Antigen retrieval methods  
Antigen retrieval is a process which helps to retrieve the immunoreactivity of a 
particular antigen after it has been lost due to tissue fixation in formalin. In this study, 
two methods were used, heat-induced treatment using microwave (for studies I-V), and 
pepsin treatment (for study III). A special microwave was used in study V. 
a) Heat-induced antigen retrieval  
This method depends on application of heat treatment to the tissue being stained using 
microwave. After deparaffinizing the sections, they were immersed in 10% Antigen 
Retrieval Buffer (ChemMate Detection Kit) (for study I), in Tris EDTA buffer (10 mM 
Tris and 1 mM EDTA, pH 9.0) (for study III) and in 10 mM citrate buffer (pH 6.0) (for 
studies II, IV,V), followed by a period of 10 minutes of heating in a microwave at 600 
W, with checking of the plastic box after the first five minutes to ascertain that it had 
enough fluid to evaporate and to avoid drying-up of the slides. In study V, the 
microwave used was programmed so that the heating cycle would run for 24 minutes at 
94 ºC. Slides were kept 30 minutes at room temperature to cool them down.  
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b) Pepsin treatment antigen retrieval  
This technique, which was applied only for study III, is based on the fact that pepsin is 
a proteolytic enzyme and thus may digest (etch) the masking proteins, thereby exposing 
the covered (hidden) antigen. In this technique, sections were immersed in a solution 
containing pepsin and distilled water (1:250) followed by addition of 1-N HCl (1:100, 
0.1 ml). All sections were kept in +37 ˚C incubator for 30 minutes and profusely 
washed with running water, and finally washed in PBS for 5 minutes.  
Primary antibodies used in the study 
The primary anti-human antibodies which were used in the studies I-V are summarized 
below in the following table. 
 
Table 6. Primary anti-human antibodies used in this study  
 
 
Antigen Antibody Source Subtype Concentration 
μg/ml 
Manufacturer 
α-defensin-1 Polyclonal Goat IgG 20 Chemicon, Canada 
RANKL Monoclonal Mouse IgG2b 5 R&D, USA 
Tryptase Monoclonal Mouse IgG1 1.05 Dako, Denmark 
Chymase Monoclonal Mouse IgG1 0.01 Neomarkers, USA 
CD1a Monoclonal Mouse IgG1 0.012 Dako, USA 
IL-8 Polyclonal Goat IgG 0.2 Santa Cruz, USA 
IL-8 RA Polyclonal Rabbit IgG 2 Novus Biologicals, USA 
TLR1 Polyclonal Rabbit IgG 0.8 Santa Cruz, USA 
TLR2 Polyclonal Rabbit IgG 2.6l Santa Cruz, USA 
TLR3 Polyclonal Rabbit IgG 2 Santa Cruz, USA 
TLR4 Polyclonal Rabbit IgG 1.3 Santa Cruz, USA 
TLR5 Polyclonal Rabbit IgG 1.3 Santa Cruz, USA 
TLR6 Polyclonal Goat IgG 1 Santa Cruz, USA 
TLR7 Polyclonal Goat IgG 0.8 Santa Cruz, USA 
TLR8 Polyclonal Rabbit IgG 1 Santa Cruz, USA 
TLR9 Polyclonal Rabbit IgG 0.5 Santa Cruz, USA 
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Programmable Tech Mate staining robot 
In the first study (study I), tissue sections of both CHC and LP were stained using the 
ChemMate staining system. In this automatic immunostaining protocol, sections were 
run through three washes in buffer containing carrier protein, detergent and 
preservative and contributing to blocking of non-specific tissue binding of the 
immunological reagents used in the protocol. Then the sections were incubated in 20 
µg/ml goat anti-human α-defensin-1 IgG (Chemicon, Temecula, CA) in antibody 
diluent for 30 minutes at room temperature, 2 µg/ml biotinylated rabbit anti-goat IgG 
for 25 minutes, endogenous peroxidase block solution for 8 minutes and finally with 
streptavidin conjugated highly purified horse radish peroxidase and 0.03% H2O2 with 
concentrated diaminobenzidine (DAB) as chromogen (160 μl of DAB) in horse radish 
peroxidase substrate buffer. Sections were counterstained for 30 seconds with Mayer’s 
haematoxylin solution before mounting. 
ABC staining 
Avidin-biotin-peroxidase complex (ABC) staining was applied for studies II-V. In this 
protocol, the endogenous peroxidase enzyme activity of the tissues was quenched by 
keeping the sections in a solution containing 1.5 ml of 30 % H2O2 diluted with 150 ml 
methanol, for 30 minutes at room temperature. To avoid nonspecific staining, the 
sections were incubated with normal serum (the normal serum of the species in which 
the secondary antibody was produced) (1:50 in 0.1% BSA, Vector Laboratory, 
Burlingame, UK) for 1 hour at room temperature. The sections were then incubated in 
the primary antibody (please refer to table 2 for details about their types and 
concentrations) and diluted according to the requirements of the experiment with 0.1% 
BSA and incubated overnight at 4ºC. Next day, all sections were incubated in 
biotinylated secondary antibody (dilution 1: 100, Vector) for 1 hour at room 
temperature, followed by incubation in avidin-biotin-peroxidase complex (ABC) 
(dilution 1:100; Vector) for 1 hour at room temperature. Finally, the sites of peroxidase 
binding were revealed with a combination of 300 µl of 3% H2O2 and 0.023% 3, 3′- 
diaminobenzidine tetra-hydrochloride solution (Sigma Chemical Co., St. Louis, MO, 
USA). All sections were counterstained with Mayer’s haematoxylin solution for 30 
seconds, dehydrated in graded ethanol, cleared in xylene and mounted in Diatex 
(Becker Industrifärg AB, Märsta, Sweden). 
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Specificity & sensitivity of the primary antibody 
During immunohistochemical staining of all the studies (I-V) the specificity of the 
immunoreaction was asserted by using some sections for negative staining control 
experiments. These control sections were stained with control antibodies of the same 
concentration (and isotype when pertinent) as the primary antibody used in this study 
(if a monoclonal antibody was used for control staining an antibody directed against 
Aspergillus niger glucose oxidase (Dakopatts, Glostrup, Denmark), an enzyme which is 
not present or inducible in mammalian tissues, was used).  
To assess the specificity of the primary antibody in study I, antigen absorption test was 
done by incubating the primary polyclonal goat anti-human α-defensin-1 IgG antibody 
with recombinant human α-defensin-1 peptide (GF 099 Chemicon, Temecula, CA, 
USA) in phosphate buffered saline containing 1% bovine serum albumin, at 1:10 on a 
molar basis, for 1 hour at room temperature.   
In study IV, to preclude any nonspecific binding of the ABC to biotin of the yeast, new 
sections of CHC were incubated in avidin-biotin-peroxidase complex (ABC) (dilution 
1:100; Vector) for one hour at room temperature. Then all steps were followed as 
mentioned above. No positive staining could be seen in the control sections. 
Western blotting 
Western blotting technique was used in study II in which mast cells were investigated 
to assess if they contain RANKL. 
a) Cell lysis 
The cell pellet of 105 human umbilical cord blood-derived mast cells sensitized with 
IgE and activated with anti-IgE IgG was lysed with 25µl Passive Lysis Buffer 
(Promega Corporation, Madison, WI, USA) with gentle shaking at room temperature 
for 30 minutes. The cell debris was removed by centrifugation at 13 000 g for 10 min at 
+4˚C and supernatant was stored at -70˚C. 
b) Gel electrophoresis and immunoblot analysis 
Cell lysis and culture media (10µl) were mixed with sodium dodecyl sulphate 
containing sample buffer (5µl) (New England Biolabs, Beverly, MA, USA). The 
samples were boiled for 5 minutes, and applied to the gels. Sodium dodecyl sulphate 
polyacrylamide gel electrophoresis was performed with a 12% polyacrylamide slab gel. 
After electrophoresis; the gels were blotted onto polyvinylidene fluoride (Millipore 
Corporation, Bedford, MA, USA).  
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After blocking overnight with a 3% bovine serum albumin in Tris buffered saline 
blocking solution and a ten minute incubation in washing solution (0.1% Tween 20, 50 
mM Tris-HCl, 0.5 M NaCl, pH 7.5), blotted membranes were incubated with affinity 
purified polyclonal rabbit anti-human sRANK ligand antibody (0.4µg/ml dilution with 
washing buffer containing 2% bovine serum albumin) (PeproTech, Rocky Hill, NJ, 
USA) for two hours at room temperature. The membranes were then washed with 
washing buffer for 30 minutes with at least 3 changes of buffer. The membranes were 
further incubated with alkaline phosphatase conjugated goat anti-rabbit Ig (1:5000 
dilution with washing buffer containing 2% bovine serum albumin) (Jackson 
Immunoresearch Laboratories, West Grove, PA, USA) for one hour at room 
temperature. The membranes were then washed with washing buffer for 30 minutes 
with at least 3 changes of buffer and a final wash in Tris buffered saline (50mM Tris-
HCl, 0.9% NaCl pH7.5). The alkaline phosphatase-binding sites were revealed in ten 
millilitres of colour development solution (Alkaline Phosphatase Conjugate Substrate 
Kit, Bio-Rad Laboratories, Richmond, CA, USA) based on the colorimetric detection of 
alkaline phosphatase with a mixture of 5-bromo-4-chloro-3-indolyl phosphate (BCIP) 
and nitroblue tetrazolium (NBT). After 30 minutes the color reaction was stopped by 
washing the membranes in distilled water for ten minutes. 
Cell culture 
Cord blood-derived clusters of differentiation (CD) 34+ hematopoietic cells (Cambrex, 
East Rutherford, NJ) were cultured in StemSpan SF expansion medium (StemCell 
Technologies, Vancouver, Canada), supplemented with penicillin (100 U/ml), 
streptomycin (100 μg/ml) and gentamicin (10 μg/ml; Life Technologies, Carlsbad, CA), 
in the presence of 10 ng/ml of SCF (R & D Systems Inc. Minneapolis, MN) in an 
atmosphere containing 5% CO2 and 5% O2 for 10 weeks, after which the cells were 
cultured in the presence of 100 ng/ml of SCF, 10 ng/ml of IL-4 and 50 ng/ml of IL-6 (R 
& D Systems Inc.) in an atmosphere of 5% CO2 and atmospheric oxygen for at least 4 
weeks. The effect of serum-supplementation was investigated by adding 10% fetal 
bovine serum (FBS; Life Technologies) under different oxygen tensions to cells 
cultured for 10 weeks in serum-free and hypoxic conditions, in the presence of 
cytokines as above. The number of viable cells was counted with Trypan blue (Sigma, 
St. Louis, MO) and is expressed as mean ±SEM. 
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Statistical analysis 
In study V, the differences in expression of the TLRs in the three epithelial layers 
(upper layer, middle layer and basal layer) for the three groups (CHC, leukoplakia and 
healthy mucosa biopsy samples) were analyzed separately with Pearson’s chi-squared 
test in which the levels of the TLR expression of the epithelial cells were coded (0 = no 
expression at all, 1 = 1-24% expression, 2 = 25-49% expression, 3 = 50-74% 
expression, 4 = 75-100% expression) using the non-parametric Kruskal-Wallis test. 
Differences between the two groups (candidosis versus control, candidosis versus 
leukoplakia, leukoplakia versus control) were assessed by the non parametric Mann-
Whitney U test. All statistical analyses were performed using the SPSS version 14.0. p-
values less than 0.05 (two tailed test) was considered to be statistically significant.  
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RESULTS & DISCUSSION 
Routine histopathology (for studies I, III, IV, 
V) 
Candidal hyphae were revealed in CHC confined 
to the uppermost layers of the epithelia with 
varying degree of penetration, while in 
leukoplakia no hyphae were observed although 
some yeast cells were occasionally found on the 
surface of the mucosa in some of the samples. In 
CHC, candidal hyphae were usually growing in a 
perpendicular direction into the epithelium and 
were randomly distributed along the epithelial 
surface colonizing some areas while absent in others (Fig. 9, arrows). Numerical 
grading was used to estimate the number of yeast cells and hyphae in individual cases 
(included with the result tables of each study below). Staining of CHC sections with 
hematoxylin and eosin showed parakeratinized epithelium with clear, broad and 
bulbous rete ridges. In some areas keratin layer had eroded and the underlying 
epithelium was exposed. Individual neutrophils and microabscesses were often seen in 
the epithelia of CHC samples, whereas inflammatory cell infiltrates, composed of 
lymphocytes and plasma cells, were seen in lamina propria in all sections. 
Immunohistochemical staining 
1. Study I: α-defensin-1 in CHC 
 The antimicrobial peptide α-defensin-1 was mainly located in neutrophils. Both CHC 
and LP showed intravascular α-defensin-1 containing neutrophils, which was intense 
and uniform. In the lamina propria of CHC α-defensin-1 containing neutrophils were 
also found. There was no peri- or extracellular α-defensin-1 staining in the lamina 
propria. In the epithelium, an apparent gradient or stratification of α-defensin-1 positive 
neutrophils was obvious. This accumulation was particularly intense in heavily-
Candida-infected and neutrophil-infiltrated samples, which also contained 
intraepithelial neutrophil microabscesses (Fig. 10). The cytoplasmic staining of many 
individual neutrophils in CHC epithelia was relatively weak, but associated with peri- 
and extracellular staining. This was particularly prominent in areas of microabscesses. 
In addition, CHC epithelia contained an intense superficial band or rim of α-defensin-1 
Figure 9. Candidal hyphae (arrows) 
attacking oral epithelium 
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deposition in the uppermost epithelial cell layers (Fig. 10, 11). However, in CHC the 
number of candidal hyphae did not correlate with the number of α-defensin-1 positive 
neutrophils in connective tissue (P=0.58) or in 
the epithelium (P=0.35) (Table 7).  
In contrast, the Candida-negative, control LPs 
contained few neutrophils and very little 
immunoreactive α-defensin-1, mostly in 
intravascular neutrophils. LP epithelium was 
not infiltrated by neutrophils and no epithelial 
microabscesses or extracellular α-defensin-1 
staining was observed. 
In this work, we were interested in the eventual protective role of the α-defensin-1 
against the opportunistic pathogen C. albicans in CHC, and based on our achieved 
results we can narrate a possible step-by-step story of both the infectious and the 
defense scenes, focusing on the role of the main spot of our main study, i.e. α-defensin-
1. The first event which follows invasion of the oral mucosa by C. albicans is the 
activation of the host innate immunity that, subsequently, triggers a local inflammatory 
reaction. Neutrophils, which are capable of killing and digesting smaller invading 
microorganisms such as planktonized yeast cells in intracellular phagolysosomes 
(Sohnle and Collins-Lech 1990), are considered the 
first line of defense against such intruding pathogens, 
are alarmed and thus recruited from the intravascular 
compartment to the site of infection. In the 
extravascular tissue and with the help of some 
chemokines, e.g. IL-8, neutrophils traverse through 
the lamina propria towards the location of the 
pathogen. When neutrophils get into the epithelium 
they accumulate and form microabscesses (localized 
collection of PMNs in the epithelium). Due to their 
activation, neutrophils degranulate their contents extracellularly, and among those 
substances released is α-defensin-1. Although α-defensin-1 is released by neutrophils 
(irrespective of their location at the time of α-defensin-1 release), most of our results 
show that α-defensin-1 was concentrated in the upper most part of the epithelium. We 
Figure 11 showing the strong α-defensin-1 
rim concentration at the uppermost 
epithelium 
Figure 10. Microabscess (arrow) and a 
strong α-defensin-1 band in the uppermost 
epithelium 
 63
hypothesize an explanation of this observation. Whenever α-defensin-1 is released by 
the neutrophils, it may move along with the advancing epithelial cells as a result of the 
normal epithelial cell growth, migration and shedding cycle (epithelial flow). This will 
inevitably lead to the heavy accumulation of this antimicrobial peptide and thus to the 
formation of the obvious immunoreactive rim at the most superficial part of the 
epithelium. The presence of this α-defensin-1-rich zone might serve as a shield against 
the ingress of C. albicans in the mucosa. Formation of this neutrophil-derived and 
epithelially-deposited α-defensin-1 barrier may lead to an effective anti-candidal shield 
against new ingrowths.  
When a neutrophil faces a candidal pseudohyphen, it degranulates letting its granular 
content with α-defensins come in contact with the candidal yeast membrane and this 
can result in inhibition of the growth or even killing of the microorganism. Although 
we conducted our study with the first class of α-defensin-1, we believe that it is more or 
less similar to the behavior of the other neutrophil granule-derived α-defensin 
subclasses as far as mucosal infections are concerned.  
Neutrophils can produce, via activation of the cell surface NADPH oxidase, other 
antimicrobial substances, e.g. superoxide anion (O¯2) and hydrogen peroxide (H2O2). 
The problem with these “chemical weapons” is that their action is immediate; therefore 
they seem not to be effective enough against chronic, long standing infections such as 
CHC (Dahlgren and Karlsson 1999). Besides, even if these respiratory burst products 
succeed in disrupting the pathogen(s), they will probably damage some “innocent 
bystanders”, which can trigger an inflammatory reaction. This, however, does not 
refrain neutrophils from using other options, e.g. α-defensins. The cooperation between 
the immigrant neutrophils, which release α-defensins, and resident epithelial cells 
bestows the host an important support in terms of candidal defense (Sawaki, Mizukawa 
et al. 2002). As might seem paradoxical, we did not find a significant correlation 
between prevalence of candidal hyphae and number of α-defensin-1 expressing 
neutrophils. To justify this correlation discrepancy, we suggest that the effects of 
epithelial β-defensins may supplement the neutrophil-derived α-defensin-1. This 
synergistic action may account for the relatively low content of α-defensin-1 (produced 
by the host) compared to the amount of the existing pathogens in some cases.  
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Table 7. Alpha-defensin-1 in chronic hyperplastic candidosis (CHC) and leukoplakia 
(LP).  
 
 
 
 
− = Negative, +/− = only occasional, + = some, ++ = moderate numbers of and +++ = 
high numbers of hyphae, microabscesses, neutrophil infiltrates and α-defensin-1 
positive cells.  E = epithelium, CT = connective tissue. 
Sample Hyphae Microabscesses       Neutrophil  Dysplasia α-defensin-1 
1 CHC +++ - +++ Dysplasia moderata E+, CT +/-
2 CHC + + + No dysplasia E-, CT+/- 
3 CHC +++ + + No dysplasia E+, CT+/- 
4 CHC + + +++ No dysplasia E+, CT+/- 
5 CHC + + + No dysplasia E+, CT+/- 
6 CHC +++ + + No dysplasia E+, CT- 
7 CHC + + +++ Dysplasia moderata E+, CT- 
8 CHC + + + No dysplasia E+, CT- 
9 CHC +++ + + No dysplasia E+, CT- 
10 CHC +++ +++ +++ No dysplasia E+, CT- 
1  LP - - - Dysplasia levis - 
2  LP - - - No dysplasia - 
3  LP - - - No dysplasia - 
4  LP - - - No dysplasia - 
5  LP - - - No dysplasia - 
6  LP - - - No dysplasia - 
7  LP - - - Dysplasia levis - 
8  LP - - - No dysplasia - 
9  LP - - - No dysplasia - 
10 LP - - +/- No dysplasia - 
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2.  Study II: RANKL in mast cell (in atherosclerosis)  
In sections of atherosclerotic left anterior descending arteries taken from patients with 
coronary artery disease, we found mast cells in 
the adventitia layer, which displayed strong 
granular RANKL staining apparently confined to 
the cellular cytoplasm, without any visible signs 
of its release into the extracellular space. In 
contrast, mast cells in atherosclerotic plaques 
displayed granular cytoplasmic RANKL staining, 
which was faint and associated with pericellular 
RANKL-positive granules, apparently as a result 
of mast cell activation and partial degranulation. 
Immunocytochemistry of sections of mature human mast cells (developed from in vitro 
culture of umbilical cord blood-derived CD34+ haematopoietic stem cells) showed a 
strong and granular cytoplasmic RANKL staining (Fig. 12). Negative control did not 
show any immunostaining. In Western blotting, 
lysed mast cells displayed a band which, by its 
size and immunoreactivity, was shown to 
represent the soluble form of RANKL (Fig. 13)   
In fact, the idea of this study emerged when we 
were doing a series of immunohistochemical 
staining of some CHC sections with different 
cytokines using different antigen retrieval 
protocols. This screening and use of pepsin 
pretreatment for antigen retrieval culminated in our discovery that mast cells express 
RANKL, a finding which had not been reported before. Therefore, we decided to assess 
this observation in a well-known disease called atherosclerosis. As the name suggests 
atherosclerosis is a general term applied to any obliterating blood vessel atheroma 
formation (literally it comes from the Greek words atheroma, meaning “porridge”, and 
Skleros, meaning “hard”). We investigated the role of mast cells in terms of RANKL 
expression and whether it is involved in any mechanism behind the process of coronary 
calcification. There are many processes that are thought to contribute to the 
Figure 12. Mast cells cultured in vitro 
show positive RANKL granules 
Figure 13. Western blot of lysed mast 
cells show a band of soluble RANKL  
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development of atherosclerosis, e.g. oxidant stress (Schulze and Lee 2005). Since the 
ossified structure of the atherosclerotic plaque was found to have the same histological 
features of normal bone including trabeculae, lacunae and marrow like spaces, Maria et 
al. suggested that this structure be called “osteosome” (Jeziorska, McCollum et al. 
1998). By our discovery that mast cells form a source of RANKL, we provided new 
insight for the quantitative assessment of the cytokine RANKL in the pathogenesis of 
atherosclerosis. RANKL, which is also called osteoprotegerin ligand (OPGL), is a 
membrane-bound ligand regulating osteoclast maturation and activation (McClung 
2006). The interaction of RANKL with its receptor (RANK) or decoy receptor 
osteoprotegerin (OPG) comprises an essential step in bone physiology and 
pathophysiology. RANKL and RANK have recently been found both in the endothelial 
cells as well as the vascular smooth muscle cells (VSMCs) of tunica media of arteries, 
suggesting that RANKL-RANK interaction is important for blood vessel 
(patho)physiology (Collin-Osdoby 2004). Our study seems to expand this field by 
incorporating RANKL-positive perivascular mast cells as new actor into this system. 
Accordingly, OPG deficiency leads to osteoporosis and arterial calcification. 
Due to the uncertainty of the exact role of RANKL in the pathophysiology of 
atherosclerosis, we cannot form an opinion whether expression of RANKL has 
beneficial or harmful effects in this particular condition. It might be that RANKL plays 
a protective role in atherosclerosis by means of stimulating osteoclastic progenitors to 
mature to osteoclasts which can resorb the already formed bone in the calcified plaques, 
but this cannot be predicted based on only immunohistochemical experiments. 
The present observations demonstrate that mast cells form a potent cellular source of 
soluble RANKL, which may contribute to vascular wall inflammation and plaque 
calcification. Molecular mechanisms responsible for the role of mast cells in the 
regulation of pathological, dystrophic calcification in atherosclerotic plaques and bone 
metabolism are only now emerging. It is noteworthy, that mast cells do respond to 
mechanical stimulation. In this respect it was interesting to note that mast cells in the 
adventitia were resting mast cells, whereas mast cells in the atherosclerotic plaque were 
activated, i.e. partially degranulated. This raises the possibility that the shear stress and 
the lever effect of the hard and calcified plaque may lead to mechanical mast cell 
activation and degranulation. Degranulation leads to release of biologically active 
mediators like RANKL and also to release of mast cell proteinases and collagenase 
activators, which contribute to plaque rupture. 
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This is the first study to show that mast cells express RANKL, thereby suggesting 
another critical role of mast cells in atherosclerosis and adding another cellular source 
of RANKL to the list of RANKL producing cells already reported in the literature. 
However, whether this affects osteoclast biology in the vicinity of the calcified lesion 
or some other aspects of endothelial-smooth muscle cell interactions and vascular 
pathology remains to be elucidated.  
Therefore, mast cells in general and RANKL in mast cells in particular, together with 
its co-actors, may deserve more attention in atherosclerosis and calcified tissue 
research. 
3. Study III: Role of RANKL in CHC 
Langerhans cells, which are CD1a positive, were found in the epithelia of CHC, LP and 
healthy controls. In the epithelium of LP and healthy tissue, these CD1a positive cells 
were mostly found in the middle layer, while in CHC they formed a network which was 
seen throughout the whole epithelium: in its upper, middle and lower thirds. In CHC, 
there was an obvious match between the content of Langerhans cells, whose grading 
values ranged from high (+++) to low (+), and the estimated quantity of candidal 
hyphae in each case (Table 8). In the 
epithelium, the morphology of CD1a positive 
cells was typical of dendritic cells, whereas in 
the lamina propria, they had the more regular 
shape of inflammatory mononuclear cells. In 
some sections of CHC, Langerhans cells were 
in a very close proximity to, or even traversing 
the basement membrane (Fig. 14).  
In CHC and LP, the epithelia showed some 
RANKL immunoreaction particularly at the region of the epithelial ridges with stronger 
staining of the former than the latter. Epithelium of healthy control sections was 
completely devoid of any immunoreaction to RANKL. 
RANKL immunostaining was noticed to be dependent upon the method of 
pretreatment. In case of pepsin pretreatment, the only RANKL-positive cells in lamina 
propria were typical mast cells which in CHC displayed only faint granular cytoplasmic 
staining, with pericellular RANKL positive granules and matrix. In contrast, the 
number of mast cells was relatively low in LP and healthy control sections and RANKL 
Figure 14. CD1a LCs traverse the 
basement membrane towards the 
lamina propria 
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staining was in these cells confined to the cytoplasm without any signs of extracellular 
release of RANKL.  
If instead of pepsin, Tris EDTA heat pre-treatment was used for antigen retrieval, also 
other cells, e.g. fibroblasts and lymphocytes, were found to be RANKL positive. These 
other RANKL positive cells were more intensely stained than mast cells and they were 
distributed mainly in the subepithelial areas. Side by side comparison of pepsin pre-
treated and Tris EDTA heat pre-treated sections from the same location demonstrates 
nicely this difference.  
Neither CD1a nor RANKL positive cells were observed in negative staining controls.  
This third work supports the previous study showing that also mast cells in oral mucosa 
contain RANKL, which was in the second work described in mast cells residing in 
connective tissue. In this study, CD1a positive Langerhans cells (LCs) were found in 
mucosal sections from CHC, LP and healthy control tissues. LCs along with 
neutrophils comprise a very essential nonspecific armory which plays a pivotal role in 
extinguishing the infectious microbe C. albicans from the host. Besides their direct 
antimicrobial effects i.e. phagocytosis, dendritic cells (immature and mature) can also 
produce chemotactic factors that activate and recruit neutrophils (Scimone, Lutzky et 
al. 2005). They are considered the most potent antigen catching, processing and 
presenting cells of the immune defense system (Steinman 1991). The preferred place of 
residence for LCs is mucosa where they act as sentinels against any foreign substances. 
Our results suggest a role for CD1a LCs in the hindrance of the entry of such 
pathogens. When an antigen source, e.g. candidal cell, succeeds in invading the 
epithelial natural barrier and intrudes into epithelium, LCs which have already been 
waiting for such a situation will stand in the way of the invading yeasts and hyphae and 
will eventually capture and subsequently engulf them. Following endocytosis, LCs 
process the engulfed candidal cell and associate its degraded components (epitopes) 
with major histocompatibility complex molecule (MHC II). Dendritic cells undergo 
maturation and leave the peripheral tissue to migrate to the regional lymph nodes where 
they present the antigen to naïve T-cells (Cutler and Jotwani 2004). In the present work, 
we demonstrated and compared the presence of CD1a positive Langerhans cells along 
with RANKL positive cells in CHC with LP and healthy controls. We also assessed the 
difference in the immunological response between CHC and LP since the former is 
considered as LP superimposed by C. albicans infection. In CHC, the number of LCs 
and their pattern of distribution, however, were variable, probably due to recruitment 
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and migration. The dendritic cell numbers are debatable in other oral infections and 
inflammations, e.g. chronic periodontitis. In three separate studies, it was found that the 
number of dendritic cells increased (Saglie, Pertuiset et al. 1987), decreased (Seguier, 
Godeau et al. 2000), or did not change (Gemmell, Carter et al. 2002) in chronic 
periodontitis compared to healthy controls. We found a lot of inter- and intraindividual 
(intrasample) variation in the number and localization of CD1a positive Langerhans 
cells in CHC, which probably reflects the dynamic nature of their involvement in local 
disease mechanisms. 
Our results showed a close match between the numerical quantities of LCs in the 
epithelium of CHC sections with the numbers of candidal yeasts and hyphae. However, 
we still think that the number of LCs per se in such mucosal infectious lesions does not 
form a reliable parameter to assess the severity of the infection, since otherwise all 
CHC sections should have shown higher numbers of LCs than their Candida negative 
counterparts and comparators, i.e. LP and healthy controls, some of which did contain 
nearly equal or even higher numbers of LCs than CHC. As has been stated, LCs were 
usually found above the basal layer of mucosal epithelium in oral, nasal, 
gastrointestinal and other areas (Girolomoni, Caux et al. 2002), which was the case also 
in our LP and healthy control sections. But in CHC, however, Langerhans cells were 
seen in all epithelial regions including the basement membrane area at the epithelial-
lamina propria junction. The presence of LCs in the upper part of the epithelium can 
reflect the role of Langerhans cells in capturing and engulfing C. albicans. Once C. 
albicans (yeast or hypha) is engulfed, LCs start to migrate away from the epithelium 
towards the lamina propria where they have to traverse the basement membrane, as 
shown in the Figure 14. The trafficking capability of LCs offers a convincing 
explanation for the highly variable location of Langerhans cells throughout the 
epithelium in CHC. The second theme of this work deals with studying the expression 
of the cytokine Receptor activator of nuclear factor kappa-B ligand (RANKL) and 
comparing it in CHC with LP and healthy control. RANKL is a membrane-bound 
ligand which belongs to tumor necrosis factor superfamily. It is produced by 
osteoblastic lineage cells, mesenchymal cells, VSMCs, chondrocytes, and various 
immune cells, such as activated T cells (Hofbauer, Shui et al. 2001). 
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Table 8. Grading* of CD1a and RANKL staining in chronic hyperplastic candidosis 
(CHC), leukoplakia (LP) and healthy control (H). 
 
* (0) The structure itself is not present, (-) negative, (±) only occasional, (+) some, (++) 
moderate and (+++) high numbers of positive cell. DC= dendritic cell 
CT= connective tissue 
CD1a positive DCs    RANKL positive cells 
Cases 
 
Yeasts 
and 
hyphae 
 
Keratin DCs in epithelium DCs in 
CT  
Epithelial 
cells  
CT cells 
e.g. mast 
cells, other 
cells  
CHC-1 +++ - ++ ++ - ++ 
CHC-2 + 0 + ++ ++ +++ 
CHC-3 +++ - +++ ++ ± + 
CHC-4 + - + ++ ± + 
CHC-5 + - ++ + ± ++ 
CHC-6 +++ - +++ ++ ± ++ 
CHC-7 + - + + ++ ++ 
CHC-8 ++ - +++ + + ++ 
CHC-9 +++ - +++ ++ + +++ 
CHC10 +++ - +++              ++ ++ +++ 
Neg.  - - - - - - 
LP-1 - - ++ ++ ± ++ 
LP-2 - - ++ + ± ++ 
LP-3 - - +/- + ± + 
LP-4 - - + ++ ± ++ 
LP-5 - - ++ ++ ± + 
LP-6 - - + ++ ± ++ 
LP-7 - - + ++ + ++ 
LP-8 - - ++ ++ ± ++ 
LP-9 - - ++ - ± ++ 
LP-10 - - ++ + ± - 
H-1 - 0 ++ ++ - - 
H-2 - - ++ ++ - + 
H-3 - - + ++ - ++ 
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It binds to its receptor RANK on the surface of monocyte/macrophages, osteoclast 
progenitors, endothelial cells and antigen presenting cells leading to their differentiation 
(Matsuzaki, Udagawa et al. 1998; Burgess, Qian et al. 1999). T cells can modulate the 
function of dendritic cells (Josien, Wong et al. 1999) through release of RANKL. This 
augments the capacity of dendritic cells to stimulate naïve T-cell proliferation in a 
mixed lymphocyte reaction (Anderson, Maraskovsky et al. 1997). As we found in the 
previous study that mast cells produce RANKL, we proceeded with this observation to 
assess whether it holds true for candidal mucosal infections involving antigen 
presenting cell-T lymphocyte interactions. The antigen retrieval methods seemed to 
affect the results of RANKL staining. When we treated the samples, which were 
formalin-fixed and paraffin embedded, with pepsin digestion, mast cells could be 
specifically studied as probably all cells containing cell surface bound RANKL become 
negative. In contrast, when Tris EDTA heat treatment was used for antigen retrieval, 
other RANKL-producing cells were also visible and stained positively, including 
lymphocytes and fibroblasts. We suggest that the different location of the antigen 
(RANKL) in different cells as well as to the mechanism of action of the antigen 
retrieving agent, may account for the disparity of RANKL staining. Pepsin is a 
proteolytic enzyme so its use entails the risk of cleaving some molecules exposed on 
the cell surface. In this way, pepsin appears to destroy most of RANKL proteins which 
were expressed by cells containing RANKL on their surfaces. In mast cells, however, 
RANKL seems to be stored in cytoplasmic granules. Since pepsin cannot penetrate 
plasma membranes (either cellular or in particular granular) composed mostly of lipid, 
RANKL proteins located in mast cells avoids the splitting action of pepsin. The Tris-
EDTA based solution, on the other hand, is designed to break the protein cross-links, 
without endangering the antigen proper itself. Thus, all RANKL positive cells were 
seen after this method of antigen retrieval. This type of fixation artefact can be used if 
in particular the eventual role of mast cell RANKL is in focus of interest.  
In CHC, RANKL-positive mast cells had weak staining apparently due to release of 
their RANKL laden-granules extracellularly, while in LP and healthy controls RANKL 
staining of the mast cell cytoplasm was stronger and completely intracellular. This 
observation might signify an active role of mast cell RANKL in CHC, which is not 
taken into use in noninfectious lesion, e.g. LP, or in normal mucosa. We suggest that 
this mast cell activation and RANKL release perhaps strengthens and speeds up the 
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maturation of the RANK positive Langerhans cells, when they communicate with the 
RANKL positive T-cells. In this respect, our results may add a new aspect of the 
participation of mast cells in the immunological response against pathogens.  
4. Study IV: Role of IL-8 and its receptor in CHC 
Immunohistochemical staining revealed IL-8 and IL-8 RA in all CHC samples and to a 
lesser extent in healthy control sections. Deep microvasculature showed IL-8 positive 
endothelial cells, which was more intense than in the superficial vasculature. In contrast 
to IL-8, the intensity of staining of both deep and superficial endothelial cells for IL-8 
receptor A was much weaker and more variable. Some areas were IL-8 RA negative, 
although also strongly staining endothelia were found (Table 8). The microvascular 
endothelia in the healthy control sections were 
relatively weak in IL-8 and IL-8 RA staining 
compared to CHC (Table 9, 10). 
The basal (lower) cell layer of the CHC 
epithelium showed stronger staining of IL-8 and 
IL-8 RA than the spinous (middle) cell layer, 
whereas the granular (upper) layer was 
completely devoid of any immunoreactions 
except for very scarce staining for IL-8 RA in some of the sections. Staining of the 
healthy control epithelia was generally less intensive than their counterparts of CHC.  
In the lamina propria and among inflammatory cells, IL-8 was found in many cell 
types, including plasma cells, mast cells, macrophages and neutrophils. Heavily 
infected CHC sections, in which there was a heavy neutrophil infiltration, showed 
intense IL-8 staining of the inflammatory cells. While 
polymorphonuclear cells had migrated on to the 
epithelium where they formed intraepithelial 
microabscesses containing IL-8 RA positive 
neutrophils, mononuclear inflammatory cells were 
retained in the submucosa. Negative staining controls 
confirmed the specificity of the staining.  
Figure 15 showing the positive 
reaction of the mother cell of C. 
albicans to IL-8 
Figure 16. The tip of C. albicans 
hyphae seems to be positive to IL-
8RA  
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IL-8 and IL-8 receptor A in candidal cells in tissue and in agar sections 
The germs of C. albicans, which were found lying on the uppermost layers of the CHC 
epithelia, stained positively for IL-8 and IL-8 RA. Candidal cells seemed to be 
polarized so that the mature blastoconidia (candidal cell bodies) only expressed IL-8 
(Table 9, Fig. 15), whereas the hyphal tips were IL-8 RA positive (Table 10, Fig. 16). 
A set of agar sections with cultured C. albicans cells were similarly stained. These 
experiments confirmed that only the mother cells of C. albicans express IL-8, while IL-
8 RA is expressed by the outermost parts or the tips of candidal hyphae. The negative 
staining controls showed neither IL-8 nor IL-8 RA staining.  
 
Table 9. IL-8 in chronic hyperplastic candidosis (CHC) and healthy controls 
 
0 the structure itself is not present, – negative, ± only occasional, + some, ++ moderate 
and +++ high numbers of positive cells. 
 
 
              Epithelium        Lamina propria  
 
 
Cases 
 
Candidal 
mother 
cell 
 
 
Candidal 
hyphae 
 
Keratin 
layer 
 
Medium   
  layer 
 
Basal 
layer 
     
Superficial 
vascular 
endothelium 
 
Deep 
vascular     
endothelium 
1 CHC +++ + – ++ +++ + +++ 
2 CHC ++ ++ – ++ +++ ++ +++ 
3 CHC +++ ++ 0 ++ +++ ++ +++ 
4 CHC 0 0 0 ++ +++ ++ +++ 
5 CHC 0 0 – ++ ++ + +++ 
6 CHC 0 0 – + +++ ++ +++ 
7 CHC ++ ++ – ++ +++ + ++ 
8 CHC +++ ++ – ++ +++ + +++ 
9 CHC +++ ++ – + +++ + +++ 
10 CHC 0 0 – ++ ++ ++ +++ 
1 Control 0 0 0 + + + + 
2 Control 0 0 0 ++ ++ +++ +++ 
3 Control 0 0 0 + + ++ + 
Negative 
control staining 
 
 0 0 – – – – – 
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Table 10. IL-8 receptor A staining in chronic hyperplastic candidosis (CHC) and 
healthy controls  
  
 
 
0 the structure itself is not present, – negative, ± only occasional, + some, ++ moderate 
and +++ high numbers of positive cells. 
 
 
As we have previously mentioned, the first line of cells which are called to the site of 
candidal infection are neutrophils. But how neutrophils are called and recruited to the 
place of tissue insult was the objective of this fourth work in which we were interested 
in the eventual role of IL-8 (a cytokine known for its chemoattractive ability for 
neutrophils) and its receptor IL-8 RA in neutrophil-mediated defense in CHC. The role 
of cytokines, when synthesized, is to augment the defensive role of phagocytes  
(Marodi 1997). In the present study, we were able to show that especially the vascular 
endothelium and oral epithelial cells seem to react to candidosis by secretion of IL-8. 
Interleukin-8 is a chemokine which belongs to the CXC subfamily and has potent 
chemotactic effects on neutrophils both in vivo and in vitro (Baggiolini, Dewald et al. 
               Epithelium          Lamina propria  
 
 
Cases 
 
Candidal 
mother 
cell 
 
 
Candidal 
hyphae 
 
Keratin 
layer 
 
Medium   
  layer 
 
Basal 
layer 
            
Superficial 
vascular 
endothelium 
 
Deep vascular    
endothelium 
1 CHC ++ ++ ± ++ +++ +++ +++ 
2 CHC 0 0 – ++ ++ + ± 
3 CHC ++ ++ – ++ +++ +++ +++ 
4 CHC 0 0 – ++ +++ + ± 
5 CHC ++ +++ – + +++ – ± 
6 CHC ++ ++ ± + +++ ++ ++ 
7 CHC + ++ ± +++ +++ ++ ++ 
8 CHC ++ ++ – ++ +++ ± ++ 
9 CHC + ++ – ++ ++ ± – 
10 CHC 0 0 – + ++ ± + 
1 Control 0 0 0 + +++ – – 
2 Control 0 0 0 ++ ++ ++ ++ 
3 Control 0 0 0 + ++ ++ ++ 
Negative control 
staining 
– – – – – – – 
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1994). Neutrophils apparently respond to IL-8 by migrating through the vascular wall 
and lamina propria to the epithelium where the actual candidal hyphae are located. 
Once they infiltrate the epithelium, neutrophils form microabscesses and release the 
antimicrobial contents of their granules extracellularly. Probably due to the strong 
innate defense shield, candidal hyphae (despite their penetrative capacity) seldom reach 
beyond the spinous cell layer of the epithelium. There has long been a debate, due to 
conflicting data, whether C. albicans stimulates epithelial cells to synthesize IL-8 in 
vivo and in vitro (Hebert and Baker 1993). Whatever the mechanism, in this work we 
demonstrate that the growth of C. albicans in CHC is associated with relatively strong 
IL-8 and IL-8 RA staining. IL-8 is a strong chemotactic stimulus to neutrophils, but it 
may also play a role for candidal cell biology.  
The surprising observation was that mother cells of C. albicans express IL-8 (or IL-8 –
like protein), while IL-8 RA (or IL-8 RA-like protein) was localized mainly in the 
hyphal tips. Although we did not find candidal homologues of IL-8 or IL-8 RA when 
we used BLAST to assess whether C. albicans has DNA sequences coding these 
proteins, we still believe there is a possibility that C. albicans encodes such proteins 
since genomic sequencing of C. albicans has not been completed yet. These findings, 
which were first done using CHC tissue sections, were later confirmed by pure candidal 
cultures in agar. The peculiar location of the positive staining of IL-8 and IL-8 RA by 
the mother cell and hyphal tips, respectively, seems to exclude the chance of a 
haphazard occurrence. Based on our findings we assume that the continuous contact of 
C. albicans with oral epithelium in health and disease (since C. albicans comprises the 
major fungal oral microflora in about 25-75% of population) might have driven the 
fungus to evolve mechanisms counteracting host immune defenses. 
C. albicans has been demonstrated to have a property of contact sensing or 
thigmotropism (Sherwood, Gow et al. 1992). This property is important in candidal 
biofilm formation on intraoral devices such as acrylic dentures (Nikawa, Nishimura et 
al. 1998). A rather new concept referred to as chemotropism has emerged in candidal 
biology. Davies et al. argued that Candida hyphal tips could elaborate exoenzymes into 
the underlying host structure. The hyphal tips, maybe through plasma membrane 
receptors, would be able to detect if this produces any cellular breakdown products 
(Davies, Stacey et al. 1999). Based on the present work, it might be that C. albicans 
expresses IL-8 RA on its hyphal tips to be able to sense the presence of IL-8, which 
might indicate potential danger. We tentatively name this phenomenon chemophobia. It 
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first seemed somewhat paradoxical that candidal cell body itself produces IL-8 or an 
analogue. However, if the endogenous candidal IL-8 (or analogue) produced by the 
mother cell communicates with the IL-8 RA (or analogue) at the tip of the hypha, its 
repulsive effect might help to guide the growth of the hypha in a centrifugal direction, 
away from the mother cell. When the tip of the hypha has grown to a distance from the 
mother cell so that the communication between the cell body and hyphal tip ceases, this 
very same ability might help to keep the sensitive hyphal tip away from IL-8-rich areas, 
which might be or become heavily infiltrated by neutrophils. Likewise, if the hyphal 
tip-located IL-8 receptor does not sense any IL-8, C. albicans might advance until it is 
faced by some defense barrier, danger signal or nutrient. This implies that C. albicans 
might have a strategy to sense the most suitable path for epithelial penetration. 
In conclusion, IL-8 and IL-8 RA seem to be at work in host defense and may contribute 
to the recruitment and migration of neutrophils from the vascular compartment through 
lamina propria to epithelia, where they accumulate and get engaged in anti-candidal 
defense. At the same time, the evolutionary pressure may have conferred C. albicans 
the ability to utilize IL-8 system in its own survival strategy. The most straightforward 
explanation for such an arrangement would be that the candidal cell utilizes this system 
first for internal communication to direct the growth of the hyphae away from the cell 
body, followed by its use in external intelligence with an aim to keep the vulnerable 
hyphal tip away from danger 
 
5. Study V: Differential expression of TLRs in CHC  
The pattern of TLR immunostaining in the three categories of samples (i.e. CHC, LP, 
and healthy controls) was different in terms of intensity and distribution of positive 
cells. The epithelium of all sections was divided into the three classical layers: lower, 
middle and upper. In most of the samples the strongest immunostaining was noticed in 
the basal layer. In CHC the number of positive epithelial cells ranged from none (-) to 
high (+++) for different TLRs. In hyphae-rich samples of CHC all the epithelium was 
uniquely positive to TLR 4 while it showed very faint staining for TLR 2, except for 
very few cells at the very bottom (Fig. 17). The three layers of the epithelia of the CHC 
sections revealed varying degrees of immunostaining in such a way that the uppermost 
layers tended to be devoid of staining while the underlying middle layers varied in 
staining intensity from always weak (in case of TLR 2) to moderately immunopositive 
(in case of TLR 4) to heavy staining (rest of TLRs), while the lower layer was always 
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positive. The picture was different in leukoplakia where TLRs staining of the middle 
and lower epithelial layers was always positive except, in some sections for TLR 9 to 
which the tissue showed weak staining or was even negative. In contrast, the epithelial 
layers of the healthy control tissue 
were always positive except 
interestingly a few sections where 
the lower layers were very weakly 
stained or negative. 
The specificity of the TLRs 
epithelial staining was confirmed by 
the lack of immunoreactive cells in 
the negative staining controls.  
From a statistical point of view, there 
was consistently statistically 
significant lower expression of the 
TLR2 (P<0.05) among the three 
epithelial layers either for candidosis 
versus control or candidosis versus 
leukoplakia comparisons. In addition 
to that, among the upper layer in the candidosis versus normal status there was also 
significantly lower expression of the TLR3-6 (P<0.05), and in the candidosis versus 
leukoplakia there was a significantly lower expression of the TLR 6 and 7 (P<0.05). 
Interestingly, there was a statistically significant higher expression of the TLR 4 and 6 
(P< 0.05) in the leukoplakia lower layer versus controls. On the other hand, in the upper 
and middle layers these two TLRs expression were observed to be significantly lowered 
for candidosis versus leukoplakia or candidosis versus controls. 
Lower or higher expression (P>0.05 but <0.066) was also observed for different TLR 
among the three different epithelial layers. 
In this work, the immunohistochemical expression of nine classes of TLRs (TLR1-9) 
was assessed in a series of sections from CHC, LP and healthy tissue. In oral 
candidosis, TLRs serve to recognize C. albicans (usually through its cell wall 
component zymosan), thereby igniting a set of intracellular signaling cascades, which 
end in production of proinflammatory cytokines and chemokines. In this study, we 
Figure 17 showing the numerous candidal hyphae in 
chronic hyperplastic candidosis (A), in which TLR2 
staining was very faint except few cells at the very 
basal layer (B) while the same section showed strong 
staining of TLR4 (C). The same finding was noticed 
in another hyphae-rich section (D, E). 
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compared the immunochemical staining of all known TLRs (except TLR10) in sections 
from CHC, LP and healthy tissues. It has been shown that candidal cell wall 
components constitute pathogen associated molecular patterns (PAMPs) for certain 
TLRs, e.g. zymosan is recognized by TLR2/TLR6 heterodimers while mannan is a 
ligand for TLR4 (Netea, Van Der Graaf et al. 2002; Roeder, Kirschning et al. 2004). 
For practical analysis, the epithelium was divided into three layers namely; upper, 
middle and lower. All TLRs, except those which are claimed to recognize C. albicans, 
i.e. TLR2, TLR4 and TLR6, were found to be strongly positive especially by the 
middle and lower layers. This may indicate that when epithelial TLRs (i.e. TLR1, 
TLR3, TLR5-9) are not stimulated by a particular PAMP (in this context, zymosan or 
phospholipomannan), they tend (continue) to be constitutively expressed. This 
explanation is enhanced further by the staining pattern of the healthy tissue to the TLRs 
(TLR1-9) and by a previous report which has documented the expression of TLRs by a 
variety of oral mucosal cells (Mahanonda and Pichyangkul 2007). For TLR2 and 
TLR4, it was another interesting story. In two samples out of five there were high 
numbers of candidal hyphae compared to the unicellular yeasts and when stained with 
TLR antibodies, they showed very little staining of TLR2 while TLR4 was comparably 
strong, but in the other sections in which hyphae were scarce TLR4 was weaker. If we 
take the dogma of negative regulation of TLRs into account (Han and Ulevitch 2005), 
then we can suggest that TLR2 is more actively engaged in recognizing and mediating 
the effects of candidal ligand (and thus more down-regulated) in the sections which 
contained high hyphae: yeast ratio. Such findings drive us to suggest that candidal 
hyphae could direct the immune response towards stimulating TLR2 rather than TLR4 
which, otherwise, would also be weakly expressed. It has been intensely debated 
whether C. albicans could stimulate TLR 2 and 4 in a manner which is dependent on 
the fungus morphological form. Our results seem to accord the previous work of Netea 
et al. who have shown that the opportunistic pathogen can exploit TLR2 to evade the 
immune system (Netea, Van der Meer et al. 2004). The same group was the first to 
work on this the idea and demonstrated that TLR2 knockout mice had gained more 
resistance against systemic candidosis compared with wild type due to the less release 
of anti-inflammatory cytokines, e.g. IL-4 and IL-10 which are elaborated by TLR2 
activation (Netea, Sutmuller et al. 2004).  
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In this work we present a new aspect of C. 
albicans virulence in mucosal candidosis in 
the sense that candidal hyphae bring down the 
anticandidal Th1 cytokines (by evading 
TLR4), and simultaneously enhances the anti-
inflammatory Th2 process (through 
stimulation of TLR2).  
The lower layers of all epithelia of CHC 
showed wider TLRs staining, comparatively, 
than the superficial layers and this is likely 
due to the synthesis of TLRs first in the lower 
layer and then starts to decrease in quantity as 
it travels upwards along the epithelial flow for 
a variety of reasons, e.g. limited half-life and 
down-regulation.  
In leukoplakia, the strong epithelial staining 
(for all TLRs except TLR9, which was quite 
weak in some sections) extended to the 
overlying keratinous layer (Fig. 18). If the 
classical definition of leukoplakia was revised 
(please refer to the leukoplakia section in this thesis), an explanation can be stated for 
the less staining of TLR9 noticed in some sections. The definition of leukoplakia 
denotes that it is a lesion and as a result; the host defense may be elicited and activated. 
Activation of the defense system may be manifested by an exaggerated expression of 
epithelial TLRs in order to protect the already diseased underlying tissue. Another 
important clue which can be drawn from the definition is that the etiology of 
leukoplakia is not yet known and its pathogenesis has not so far been attributed to any 
microorganisms. Therefore, we consider it a logical finding that no particular TLR 
(except TLR9) was down-regulated and, therefore, probably not involved in any long-
term ligand binding. The endosomal location of TLR9 parallels its ability to recognize 
the unmethylated CpG DNA the origin of which can be bacterial, fungal or 
mitochondrial (Bellocchio, Moretti et al. 2004; Takeda and Akira 2005). Based on that, 
we suggest that, in leukoplakia, the mucosal host defense system may degrade the 
invading microbes, whether bacteria or fungi, by phagocytosis, e.g. by PMNs or direct 
Figure 18 showing the TLRs (1-9) immunostaining 
in leukoplakia. 
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lysis (by antimicrobial peptides resulting in leakage of the microbial cell contents 
including its genetic material), which would keep on stimulating TLR9 leading to its 
decreased expression. We, however, cannot generalize this assumption since it was 
found only in some sections but this again could be due to involvement of other factors, 
e.g. degree of the lesion chronicity and local immune status. 
Sections of the healthy tissue, in contrast, showed strong expression of all TLRs 
especially by the middle and superficial layers. The lower layers of some sections 
showed faint or even absent TLRs staining which may broaden the phenomenon of 
negative regulation in healthy tissue with unoccupied TLRs.  
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SUMMARY & CONCLUSION 
Candida, which is normally present on the skin and mucous membranes, such as the 
mouth, gastrointestinal tract, genitourinary tract, is the most frequently isolated fungal 
pathogen of humans. Among its many species, Candida albicans is responsible for 
most human candidal infections affecting immunocompromised patients ranging from 
premature infants to AIDS (acquired immunodeficiency syndrome) sufferers. The 
immune system of the host, under normal conditions, can maintain a strict control upon 
C. albicans should it attempt to express its pathogenic potential. It is not a necessity 
that patients be suffering from immunocompromising pathological conditions to 
become infected by such opportunistic pathogens, since age extreme individuals, i.e. 
infants and senile people, as well as denture wearers also remain suitable targets for C. 
albicans infection. In mucosal niche, C. albicans can thrive in a fertile ground with a 
moist and warm, protein-rich human mucosal membrane or biomaterial surface where 
they become activated and start to grow pseudo and real hyphae resulting in 
colonization. C. albicans can also travel through the blood stream and affect distant 
sites, e.g. brain, kidney and heart valves, and cause what is known as systemic 
candidosis.  
Infection of the oral mucosa with the opportunistic candidal infection may result in 
several clinical and histopathological forms ranging from atrophic, pseudomembranous 
to hyperplastic candidosis. We have adopted the last category (chronic hyperplastic 
candidosis) to present a model for studying the oral host defense against candidal 
invasion.  
We supposed that the host has to recognize the invading candidal microbe first through 
binding of certain components of the candidal cell wall to germ-line encoded receptors 
(the subject of study V). Once the host identifies the identity of the attacking stimulus, 
it reacts by playing many tactics, e.g. elaboration of natural antimicrobial peptides (e.g. 
defensins) and recruitment of immune cells (e.g. phagocytes). The style of α-defensin-1 
release and its manner of contribution in the defense process against C. albicans was 
investigated in study I, while the cellular scene of the host defense and the cytokines 
involved in its regulation were the focus of the other studies (II, III, and IV). Generally 
speaking, the aim of this thesis work was to draw a scenario of how the host responds 
to candidal infection of the oral mucosa in terms of natural antimicrobial peptides, 
cytokines, and cells and try to combine their tasks into a unified theme.  
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In the first work, we studied the neutrophil-derived anti-candida α-defensin-1 which 
was found in the epithelium; not only diffusely all over, but as an α-defensin-1 rich 
shield, while it was hardly seen in the lamina propria. But since the cellular source of α-
defensin-1 is neutrophil, which is recruited from the lamina propria one can ask how 
this antimicrobial peptide reaches the uppermost part of the epithelium without being 
expressed in the lamina propria? This question drove us to shape a probable step-by-
step process which went in accordance with our results and observations and some 
basic biological facts. We suggested that the neutrophils transmigrate through the 
microvasculature in the lamina propria and migrate towards the epithelium. On their 
way, they would maintain their granules intact and advance further till they reach the 
epithelium where they-upon contact with candidal germs-start to release their granular 
contents, including α-defensin-1. While neutrophils gather and organize themselves 
into microabscesses, α-defensin-1 will continue, maybe as a result of epithelial cell 
flow, advancing towards the uppermost layer of the epithelium and accumulate there, a 
process which 
may be 
responsible for the 
α-defensin-1 rich 
frontier shield.  
The second work 
(study II) does not 
need much to 
discuss because its 
main purpose was 
to confirm the 
accidental finding 
that mast cells can 
express RANKL. 
The pattern of 
mast cell staining 
was different in 
calcified plaque 
compared with RANKL-positive mast cells in the tunica adventitia. It seems that 
Figure 19 showing a schematic summary of the interplay of the different 
components of the host defense (nonspecific and specific) which were studied in 
this thesis 
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RANKL has a particular role in the calcification process on the plaque since it was 
partially released from the mast cells, while it appeared completely intracellular in areas 
not affected by plaques.   
The third work (study III) was done to check if mast cells-releasing-RANKL behave in 
the same way in CHC as in the previous work of atherosclerosis. Mast cells seem to 
react to the opportunistic C. albicans infection by local mast cell hyperplasia and 
secretion of RANKL. This may be important for the recruitment and maturation of 
antigen presenting dendritic cells and lymphocyte activation. Some sections showed 
strong mast cell staining confined to the cell cytoplasm, without any signs of 
extracellular release of RANKL. Others displayed granular cytoplasmic RANKL 
staining, which was faint and associated with pericellular RANKL positive granules, 
apparently as a result of mast cell activation and partial degranulation. Expression of 
RANKL augments the ability of dendritic cells to enhance naïve T cell proliferation in 
a mixed lymphocyte reaction. Dendritic cells and T lymphocytes comprise an important 
category of immune system against fungal infections. Therefore, mast cells seem to 
participate in the immunological processes conducted by the host against such a 
pathological insult. 
The fourth work (study IV) was conducted to examine the presence and effects of the 
neutrophil chemokine IL-8 and its receptor IL-8 RA in CHC. We found that most of the 
host tissue produces IL-8 at high concentrations, e.g. epithelium, endothelium and 
inflammatory cells, which would activate neutrophils and lead to their degranulation. 
The most important and novel observation was that the candidal cell body showed IL-8-
like immunoreaction whereas the tips of the candidal hyphae expressed IL-8 RA-like 
immunoreactivity. This is very interesting as we speculate that endogenous candidal-
derived IL-8 at low concentrations could lead to centrifugal growth of the hyphae, away 
from the candidal cell body, via interactions of IL-8 with its receptors at the hyphal tips. 
At the same time, hyphal IL-8RA could prevent the tips from intruding into dangerous 
areas where neutrophils will soon migrate or where they are already located. 
In the fifth and last piece of work, a comparative analysis of TLRs (TLR1-9) 
immunostaining in CHC, LP and healthy control was undertaken. From this 
experiment, we concluded that the resultant immune response following C. albicans-
TLR binding depends largely on the morphological form of the fungus. In other words, 
C. albicans seems to take advantage of its projecting hyphal form in eluding the host 
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defense by means of directing the immune defense towards TLR2 rather than TLR4. 
When oral epithelium is infected with yeast-dominated candidosis, TLR4 seems to be 
more involved than TLR2. In leukoplakia, the weak status of the diseased tissue makes 
it vulnerable to further infection and this may explain the strongly positive TLRs 
staining (except TLR9 which, in some sections, showed weak staining possibly due to 
their engagement with the nuclear material of any invading microbe).  
To summarize, the above long story can be shortened and sectioned into one complete 
scene (omitting some unnecessary details): The mouth encompasses many candidal 
cells which are floating around, some are attached. Some such candidal cells attempt to 
establish adherence to the oral epithelia and invade the underlying tissue. We have two 
scenarios here. If the host is healthy, such attempts will be doomed to failure due to the 
strong physical integrity of the epithelium and the strict host defense. If the immune 
status of the host is compromised, unpleasant consequences may follow. Once C. 
albicans attaches to the oral epithelium, it will be recognized by TLR2, 4 and 6. Based 
on literature analysis and the pattern of TLR expression, the most important of these in 
recognizing C. albicans seem to be TLR2 and 4. If the invading cells have more 
unicellular yeast form, TLR4 responds more extensively and the subsequent immune 
response against candidosis will be promoted through elaboration of pro-inflammatory 
cytokines and chemokines. IL-8 is important as it recruits the neutrophils to the 
uppermost layers where the candidal germs are located. During their upward 
movement, they release some of their α-defensin-1 extracellularly till they reach the 
superficial layers where they group themselves into collections known as 
microabscesses (Fig. 19). When the host senses that the infection is going to persist 
longer (become chronic), antigen-presenting cells are engaged into the host defense in 
order to pave the way for the more sophisticated specific immune defense. These 
epithelial dendritic cells are Langerhans cells, which under such circumstances are 
recruited to the epithelium where they engulf candidal cells (either by zipping or 
coiling), leave the mucosa and in the regional lymph node present the antigen to naive 
T cells. During their journey, they get augmented by RANKL secreted by resident mast 
cells, so that they become more effective in communicating with T cells. On the other 
hand, C. albicans seems to have developed some means to avoid the host defense. One 
aspect is that when more hyphae are encountered in the infection, then the receptor 
stimulation may shift towards TLR2 which results in production of anti-inflammatory 
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cytokines, thereby propagating the potency of the infection. Another smart technique is 
the ability of the fungus to produce IL-8 or an analogue by the mother cell and express 
its receptor IL-8RA at the hyphal tip so that it can stimulate itself in an autocrine 
manner to drive the projecting hyphae away from the cell body. This apparent 
chemophobic phenomenon may also serve to save the sensitive and more important part 
of the candidal body (i.e. the hyphal tip- used in thigmotropism and chemotropism) 
should it sense any risk for approaching neutrophils. 
In the end, although the study of the pathogenesis of the opportunistic pathogen C. 
albicans and the host defense against it has advanced progressively, there are still many 
interesting puzzles which remain to be resolved. First, why does C. albicans thrive only 
in some people? Second, when the host is healthy, why does not C. albicans cause any 
infection? Is it because it stays merely commensal or it actually expresses some 
pathogenic features which are immediately abrogated by the strong host defense? In 
case it exerts its pathogenicity only when the host immunity is compromised, how does 
it sense the change in the defense status? Third, out of study 5, how do candidal 
hyphae, but not yeast, elude the host response by directing its stimulation towards 
TLR2? Fourth, is there any purpose behind C. albicans chemophobia other than 
avoiding the source of danger i.e. neutrophils? Fifth, why is it very rare, if ever, that C. 
albicans could invade the mucosa beyond the spinous layer? Is it because of the strong 
shield of the epithelium, or are some other factors involved? Sixth, what is the nature of 
epithelial anti-Candida activity? Seventh, I wish if researchers, in the future, could 
reach a clear and satisfactory defintion of LP because the one in use today is a bit 
confusing and ambiguous. Eighth, regarding atherosclerosis, what is exactly the role of 
RANKL in the pathogensis of the disease? Is it a causative factor or an effect?  
Therefore, further efforts are needed to reveal other anti-Candida host defense 
mechanisms. This might aid in paving the road towards lowering the incidence of 
candidosis (whether mucosal or systemic) by improving the current medications and 
developing new therapeutic modalities.       
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